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Heart disease is a major cause of morbidity and mortality in the United States with coronary 
artery disease (CAD) representing more than half of all cardiovascular events.  Stable patients 
presenting with symptoms suggestive of CAD are likely to undergo either an exercise ECG 
and/or imaging study as a first line diagnostic assessment.  A cardiopulmonary exercise test 
(CPX) is an ECG stress test plus ventilatory gas analysis.  Recently CPX has been used to detect 
exercise-induced myocardial ischemia suggestive of underlying CAD.  Currently there are a 
number of diagnostic tests available for the identification of CAD with the most widely used 
being exercise ECG, myocardial perfusion imaging (MPI) and cardiac catheterization.  Exercise 
ECG, although inexpensive, has a number of well-recognized limitations, including low 
sensitivity resulting in false positive results.  MPI and catheterization are more accurate but also 
more invasive and expensive.  It appears that CPX may improve the diagnostic accuracy of 
exercise ECG in a cost effective manner.  This dissertation consists of one literature review and 
  
two original papers that will address the utility of CPX in patients being evaluated for possible 
myocardial ischemia. 
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Introduction 
Cardiovascular disease is expensive and the cost is paid in lives lost and dollars spent.   
Indeed, the number of Americans with some form of heart disease is staggering.  In 2005 the 
prevalence of heart disease in the US was nearly 81 million, and the prevalence of stroke nearly 
6 million.  Although primarily a metabolic disorder, the leading cause of death in patients with 
diabetes is cardiovascular disease and in 2005 the combined prevalence of diabetes and pre-
diabetes was nearly 75 million. The annual cost of cardiovascular disease in the US is 
approximately $450 billion and accounts for more than 1/3 of all deaths, with almost 2400 each 
day. 
1
     
Coronary artery disease (CAD) makes up more than half of all the cardiovascular events 
in men and women 75 years or younger.
1
  A large percentage of the costs associated with CAD 
are for diagnosis and evaluation, including those for the determination of disease severity and 
efficacy of treatment.  Clinicians use a mix of invasive and non-invasive tests with a wide range 
of costs to evaluate patients with suspected or confirmed CAD.  An estimated 7 million inpatient 
cardiovascular operations and procedures are performed each year and cardiac catheterization, 
the gold standard diagnostic tool for the detection of coronary artery stenosis, represents nearly 
1.6 million of those.  The mean charge for patients hospitalized for this procedure increased from 
$11,611 in 1993 to $26,910 in 2005.
1
  
Cardiac catheterization is usually the first test to be performed in a patient with symptoms 
of an acute myocardial infarction.  Stable patients presenting with symptoms suggestive of CAD 
are more likely to undergo either an exercise ECG (the typical “stress test”) and/or an imaging 
study (myocardial perfusion imaging or echocardiography) as a first line diagnostic assessment.  
Many of these rely on the use of either exercise or pharmacological stress to sufficiently augment 
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myocardial oxygen demand.  In addition to recording the ECG response, the stress portion of the 
test is used primarily to achieve the appropriate heart rate to assure diagnostic accuracy of the 
imaging study and typically none of the exercise data is considered in the final analysis.   
However, it is known that assessing the hemodynamic response to exercise, such as heart 
rate recovery
2
, yields powerful clinical information and the same is true for information gained 
from ventilatory gas analysis.  A cardiopulmonary exercise test (CPX) is one with ECG 
monitoring plus ventilatory gas analysis.  That is, during the test all of the air inspired and 
expired by the patient is collected and analyzed.  CPX has been widely applied to the evaluation 
of heart failure where it is routinely used to determine disease severity and prognosis.
3-8
   It is 
also well-recognized for its ability to differentiate between cardiac and pulmonary causes of 
unexplained dyspnea. 
9-12
  Furthermore, CPX is increasingly utilized in the diagnosis of 
pulmonary hypertension.
13-15
  See Table 1 for a full listing of the current clinical indications for 
CPX.  
Recently CPX has begun to emerge as a tool to diagnose CAD but there remain 
unanswered questions.  Therefore, this review will discuss the use of CPX in the identification of 
suspected or confirmed CAD.  First, a description of the principles of exercise physiology 
relevant to CPX will be presented.  Next, normal and abnormal myocardial physiology will be 
described, including the pathophysiology of CAD and the rationale for the use of CPX in 
detecting exercise-induced myocardial ischemia (EIMI).  The most frequently applied diagnostic 
tools will be briefly presented with a focus on their diagnostic accuracy.  Finally a literature 
review will provide the reader with a sense of what has been demonstrated to-date followed by a 
discussion of how this body of evidence might be advanced.   
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Exercise Physiology and Exercise Testing Review 
A detailed description of the CPX instrumentation needed for data collection and analysis 
is beyond the scope of this review however a brief overview is provided in Figure 1.   
What is vital to understanding the physiological basis for CPX is the interconnectedness of the 
cellular, pulmonary, and cardiovascular mechanisms involved in the acute exercise response.  
Oxygen is the primary molecule involved in the creation of adenosine triphosphate, the major 
fuel source necessary for all metabolic work.  At rest the cardiopulmonary system works in a 
coordinated fashion to deliver adequate oxygen to fuel the cellular respiration underlying the 
conversion of chemical energy to mechanical energy.   Almost immediately upon the initiation of 
exercise, the demand for ATP increases, increasing the demand for oxygen and causing a greater 
ventilatory drive.  Thus, oxygen consumption (VO2) can be thought of as a surrogate for cellular 
activity.  The Fick Equation describes the acute physiological response to exercise: 
Q = VO2/arterial – venous O2 difference 
Q represents cardiac output and is the central (i.e. cardiac) contribution to oxygen 
consumption (VO2).  The cardiovascular system couples to the respiratory system by sensing the 
increase demand for oxygen and responds with a greater cardiac output (CO), the product of 
heart rate (HR) and stroke volume (SV).   An increase in ventilation with exercise, and therefore 
an increased oxygen demand, must be matched by an increase in blood flow.  Venous return is 
augmented by several mechanisms.  First, venous constriction results in a greater preload and 
therefore an increased CO.  This causes a dilatation of the pulmonary capillaries providing blood 
flow to alveoli previously un- or under perfused.  At the same time, blood flow to the working 
skeletal muscle is augmented by arterial vasodilation while splanchnic vasoconstriction shunts 
blood away from the abdominal viscera.
16
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Substituting HR * SV for Q gives the following: 
HR * SV = VO2/arterial – venous O2 difference 
This final term represents the peripheral component of oxygen consumption, the arterial – 
venous O2 difference (a-vO2 difference), which is the difference in oxygen content between the 
veins and the arteries.  At rest, oxygen extraction is approximately 30-40%.  During exercise a 
larger percentage of oxygen is unloaded from the blood into working skeletal muscles.  Arterial 
oxygen content (PaO2) rises only slightly and the greater a-vO2 difference is explained primarily 
by decreased venous oxygen content (PvO2) due to increased extraction by the metabolically 
active muscles.  Finally, what remains is the following rearrangement of the Fick equation, 
which is the basis for CPX: 
VO2 = (HR *SV) * a-vO2 difference 
Importantly, the largest contributor to maximal/peak VO2 is maximal CO and positive or 
negative alterations in the former are primarily explained by shifts in the latter.  In addition to 
VO2, numerous other variables, both ventilatory and non-ventilatory, are collected during a 
routine CPX.  See Table 3 for a full listing of the most commonly assessed variables.   
While a number of variables can be derived from ventilatory gas analysis, real-time tracking of 
the O2-pulse and change in VO2/change in work rate (VO2/WR) have been most thoroughly 
investigated in subjects with suspected or confirmed myocardial ischemia.  Normal and 
abnormal responses for these CPX variables are illustrated in Figures 2 and 3, respectively. 
 
Myocardial Oxygen Consumption 
Like skeletal muscle, the myocardium depends on the generation of ATP for the 
conversion of chemical energy into mechanical work.  For optimal function myocardial 
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metabolism is primarily oxidative, with a preference for fatty acids in the fasted state and 
carbohydrate in the fed state.   Analogous to whole body oxygen consumption (VO2 = CO * a-v 
O2 difference) myocardial oxygen consumption is also determined by blood flow and oxygen 
extraction.  Whereas resting oxygen extraction in skeletal muscle is quite low (30-40%), in some 
regions of the heart it is 70-80%.  The functional consequence of this difference is that during 
exercise skeletal muscle has two ways to increase oxygen supply.  The first is vasodilation (to 
increase delivery) and the second is increased oxygen extraction.  The latter is largely not an 
option for the myocardium, especially the left ventricle.  Thus, the only way to improve oxygen 
delivery is to increase blood flow.
17
   
 Blood flow to the heart is supplied by the coronary arteries which arise from the aorta just 
superior to its semilunar valve.  Two main arteries, the left and right coronary arteries and their 
branches, supply all of the blood to the myocardium.  Although there is a variation among 
humans the typical territory supplied by each epicardial artery can be generalized.  The right 
coronary artery primarily supplies the right atrium and ventricle, the SA and AV nodes and part 
of the AV septum.  It also may help to supply the left ventricle.  The left coronary artery supplies 
the left ventricle and atrium, part of the right ventricle, the interventricular septum and 
sometimes the SA node.   
Coronary blood flow at rest is determined by perfusion pressure and coronary resistance, 
with the latter being the largest contributor.  Perfusion pressure is provided by aortic pressure at 
the outset and is impacted by the back pressure exerted by the contracting myocardium, called 
extravascular compression.  This pressure is significant enough to cause a cessation or even a 
reversal of flow through the coronary arteries during systole at rest.  Therefore at rest the 
coronary arteries are perfused during diastole.  During exercise systolic filling is increased.  This 
9 
 
is especially important under pathological conditions, especially hypertension and coronary 
artery disease.  In both cases perfusion of the coronary arteries may become more difficult, 
exacerbating the consequences of the already-reduced flow.
18
   
Coronary resistance is set not by the large epicardial coronary arteries, but rather by the 
small arteries and arterioles
19
 and is determined by the diameter and length of the vessels, as well 
as the number of vessels in parallel, supplying a specific area of myocardium.
20
  Vessel diameter 
can change in response to neural input, local metabolites, such as Angiotensin II, ATP and 
adenosine, and endothelium-derived vasoactive agents such as nitric oxide and endothelin.
21
         
Autonomic influence on the heart is primarily neurally mediated however experiments in 
denervated hearts show that this is not the only mechanism.  The heart is influenced by a variety 
of neurotransmitters working on different receptors including adrenergic and muscarinic.  
Parasympathetic control of the heart is mediated by acetylcholine which acts on muscarinic 
receptors to slow heart rate and reduce contractility and conduction velocity of the AV node and 
automaticity of the SA node.  Alpha adrenergic influence is primarily vasoconstrictive and serves 
to reduce coronary blood flow.  Beta adrenergic activation typically results in vasodilation and 
increased coronary blood flow.
22
 
 In accordance to their function, the four chambers of the heart require different amounts 
of oxygen.  Myocardial oxygen consumption is greatest in the left ventricle (followed by the 
right ventricle and then the atria) and this is due to greater total blood flow and higher levels of 
oxygen extraction compared to the other chambers.
22
  During exercise the increased myocardial 
oxygen demand is due mainly to an increase in heart rate
23, 24
 contractility
25-29
 and left ventricular 
work
28, 29
.  During exercise, taking into account the constraining effect of the extravascular 
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compression forces, perfusion pressure is increased approximately 20-30%.
30
  During exercise, 
change in resistance is the primary means by which blood flow is increased.
21
  
 
Atherosclerosis and Coronary Artery Disease 
Atherosclerosis is an inflammatory condition affecting primarily the intimal layers of 
medium to large coronary, cerebral and lower extremity arteries.  Endothelial damage causes the 
accumulation of oxidized LDL and the recruitment of additional inflammatory agents which can 
themselves result in more injury and induce further vascular dysfunction.[31, 32]  
Atherosclerosis of coronary arteries has many consequences, including reduced blood flow to the 
myocardial territory supplied by that vessel.  Under conditions of mild ischemia, preferential 
resting substrate utilization changes from fatty acid oxidation to glycolsysis.  This represents the 
body’s effort at improving efficiency because the oxidation of glucose requires fewer oxygen 
atoms per ATP produced (although fewer total ATP are formed).  Concurrently fatty acid 
oxidation is inhibited resulting in accumulation of this cardiotoxic substrate.  As ischemia 
proceeds the production of ATP is drastically reduced by this and by reduced glucose transport 
due to the low/no blood flow conditions.[17]   
When a coronary artery is stenotic due to atherosclerosis there is increased perfusion 
pressure proximal and decreased perfusion pressure distal to the blockage.  Once this situation 
reaches a critical level, defined as a 50-70% reduction in luminal diameter depending on the 
specific vessel, coronary flow reserve (maximum blood flow/basal blood flow) is reduced due to 
an increase in resistance across the affected artery.  If post stenotic pressure falls below 40 
mmHg the myocardium fed by that vessel will become under perfused and potentially 
hypoxic.[33-35] The effect of extravascular forces is exacerbated in the presence of a blockage, 
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especially in the face of high diastolic pressures or diastolic dysfunction.[22]  At rest 
homeostasis may be achieved, however during periods of physical exertion, the demand for 
oxygen may outstrip the ability for it to be supplied.   
 
Examination Techniques for the Diagnosis of CAD 
The most widely used tools to diagnosis CAD rely on the assessment of coronary artery 
physiology and/or anatomy, as described above.  All of these methods have advantages and 
limitations which impact their effectiveness.  The following section describes the most 
commonly used tests (exercise ECG, myocardial perfusion imaging, echocardiography and 
cardiac catheterization) and introduces the potential utility of CPX.  Table 4 provides details 
related to costs, diagnostic accuracy and limitations.   
The ECG has played a prominent role in the long history of the diagnosis of CAD.  It is 
considered a standard portion of any exercise test, one which does or does not utilize ventilatory 
gas analysis.  Pathological processes such as atherosclerosis can change the appearance of ECG 
waveforms, in particular the QRS complex and the T wave.  The ST segment is the portion of the 
ECG waveform most often used in the diagnosis of ischemic disease and is defined as the end of 
the QRS complex, called the J point, to a user defined interval, usually 0.08 seconds.  Changes to 
the ST segment manifests as elevation, depression or normalization. ST segment changes can 
result from pathologies other than CAD, including valvular heart disease, congenital heart 
disease, cardiomyopathy, and pericardial disorders.  They are also associated with gender, some 
pharmaceutical agents, electrolyte abnormalities, testing in a non-fasting state, electrical 
conduction abnormalities and inadequate equipment.
16
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ST segment elevation is less common than depression and is believed to be indicative of 
more severe transmural or epicardial ischemia and possibly localizable to the myocardial area 
from which it is recorded.  There is some debate on whether elevation is reflective of ischemia or 
wall motion abnormalities and the answer may be dependent on the cardiac history of the 
subject.  ST segment depression is the most common ECG change associated with EIMI and its 
physiological basis is subendocardial ischemia.  The ECG leads in which it appears are not 
reflective of the location of the ischemia or the arteries affected.  ST depression can be down 
sloping, horizontal, or up sloping with severity being greatest in the first followed by the second 
and third.  However, the amount and slope of the depression are related to the probability and 
severity of disease.  ST segment changes appearing only in recovery from exercise appear to be 
of some clinical value.
16
    
The diagnostic accuracy of the exercise ECG stress test has been thoroughly reported in 
the literature.  The primary limitation is that various cardiac pathologies affect conduction, and 
therefore the appearance of the ECG.  Additionally, the ST segment appears to be differentially 
impacted by gender with more women demonstrating conduction patterns suggestive of ischemia 
at rest.  In one large meta-analysis that included nearly 150 studies and approximately 24,000 
subjects, Gianrossi
31
 reported the range of sensitivity to be 23-100% (mean 68%) and the 
specificity to be 17-100% (mean 77%).  A separate analysis excluding those with a history of 
myocardial infarction resulted in a reduction of the mean specificity to 74%.  Similar reductions 
in diagnostic accuracy are found when the effects of digoxin, left ventricular hypertrophy and 
resting ST depression are removed from the analysis.
16
   
 From 1993-2001 the use of non-imaging stress tests, such as exercise ECG, declined in 
all groups except black males.  During the same period the use of imaging stress tests, for 
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example myocardial perfusion imaging and echocardiography, increased from as low as 20 per 
1000 (black females) to as many as 100 per 1000 (nonblack males).
32
  Myocardial perfusion 
imaging (MPI) has become the most commonly employed imaging test for the detection of stable 
coronary artery stenosis.
33
    This technique uses radioactive tracers (thallium or technetium are 
the two most common) and imaging, via single photon emission computed tomography 
(SPECT), to identify hypoperfused regions of myocardium.  The myocardium will take up these 
tracers to the same level if all areas are equally perfused.  Areas with reduced blood flow, either 
at rest or during stress (exercise or pharmacologically-induced), will exhibit areas of attenuation. 
If no attenuation is evident on the stress images, acquiring rest images is considered by most to 
be superfluous.  The addition of ECG gating (ECG-gated SPECT) allows the nuclear perfusion 
study to also capture data on LV wall motion, thickness and function. 
 The diagnostic accuracy of MPI SPECT is reported in the range of 87-89% for sensitivity 
and 73-75% for specificity.  Accuracy is impacted by the extent of previous myocardial injury, 
the presence of resting perfusion abnormalities without the benefit of a “normal” comparison and 
poor imaging quality due to adiposity or other patient characteristics.  Additionally, for 
pharmacologically-induced stress studies, perfusion abnormalities might not correlate well with 
functional limitations.   
 Another imaging test, stress echocardiography, uses rest and stress images to detect 
changes in wall motion, wall thickness and LV function to identify ischemia.
33
  The stress can be 
exercise or pharmacologically-induced, although it appears diagnostic accuracy is improved with 
the former.  Exercise echocardiography has been shown to be especially effective in women and 
those with baseline conduction abnormalities who have a high rate of false positive ECG 
findings.  In these patients echocardiography may also be more cost-effective.
34-36
  One 
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limitation of echocardiography is obtaining images when the visual field is obstructed by 
adiposity or other anatomical obstruction.   
 At the far end of the invasiveness spectrum is cardiac catheterization, the gold standard 
for detection of coronary artery stenosis.
33, 37
   However, limitations exist, chief among them 
being the lack of correlation between structure and function.  That is, luminal narrowing may be 
present in the absence of symptoms or symptoms may be present in the absence of obvious 
stenosis.
38
  Furthermore catheterization carries risks of adverse events the treatment of which, 
even if they are minor, adds to the already steep cost of the procedure.  For this reason and 
others, catheterization should only be performed in patients with a high pre-test probability of 
having CAD.  In this way catheterization serves the role of confirming disease and providing the 
gateway to immediate intervention more so than providing an initial diagnosis for those with 
stable CAD.   
Additional tests for the detection of clinically significant stenosis include cardiac MRI, 
and computed tomography (CT).  Although a detailed description of these methods is beyond the 
scope of this review because of their lack of widespread use, information related to their 
diagnostic accuracy is included in Table 4. 
 The power of CPX to identify EIMI lies in its acute sensitivity for detecting changes in 
oxygen consumption and carbon dioxide production in real-time.  It may be especially well-
suited to the consequences of myocardial ischemia because of the absolute reliance of cardiac 
muscle on oxygen.  That is, during exercise the demand for oxygen is directly related to the 
demand for ATP.  If this demand is not met, ATP production will fall and subsequently 
contractility will suffer.  Left ventricular dysfunction will nearly instantly ensue reducing the 
heart’s pumping ability.  Cardiac output will be diminished reducing oxygen delivery to the 
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working skeletal muscle and whole body oxygen consumption will fall.  Not only will systemic 
circulation be affected, but pulmonary circulation, too.  Delivery of blood back to the heart will 
also suffer, reducing expired carbon dioxide.  These consequences will be reflected in many of 
the variables assessed with CPX.   
 
Literature Review for CPX use in Detecting EIMI 
 The use of CPX in the evaluation of CAD began at least 30 years ago with research 
linking the effects of myocardial infarction with left ventricular (LV) function and has 
progressed to the more generalized condition of reduced myocardial blood flow.  More recently, 
several investigations have used oxygen consumption as a surrogate for real-time cardiac output 
to describe the acute consequences of exercise-induced ischemia.  To-date, very few studies have 
reported on the use of CPX as a primary tool to diagnose myocardial ischemia.  However, there 
is an apparent evolution in the literature beginning with attempts to understand LV function, 
progressing to the analysis of ventilatory gas as a marker of underlying myocardial ischemia and 
finally descriptions of the effects of specific pharmaceutical agents or surgical intervention on 
LV function and exercise capacity.  These investigations have been limited in scope but hint at 
the potential utility of CPX in the diagnosis of CAD.  The following is a description of those 
studies (additional details can be found in Table 5) 
 
Investigations Using Exercise Testing/CPX to Diagnose CAD 
In 1980 Upton et al
39
 built on work demonstrating LV dysfunction after coronary artery 
ligation in an animal model.  On this principle, the temporal relationship between LV function, 
and angina and ST segment changes in a group of patients with CAD was investigated.  This 
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important study demonstrated the presence of LV dysfunction prior to the onset of angina or ST 
segment changes.  The LV dysfunction during exercise was characterized as a decrease or a less 
than 5% increase in ejection fraction (EF), a greater than 25% increase in end diastolic volume 
(EDV) or an increase in end systolic volume (ESV).   Ehsani et al 
40
 confirmed Upton’s finding 
of a decrease in EF during exercise in patients with asymptomatic CAD (silent ischemia) which 
was significantly correlated with other CPX variables.  In this study all patients had a normal EF 
at rest.  During exercise some patients had an increase in EF while others experienced a decline.  
In those with a decrease, O2-pulse was also significantly lower, as was total exercise time, HRmax 
and VO2max.  This work also confirmed earlier findings that resting EF was not significantly 
correlated with exercise capacity (VO2max), however there was a weak but significant correlation 
between VO2max and peak EF.   
Koike et al
41
 demonstrated in a heterogeneous heart disease population that the anaerobic 
threshold correlated with the VO2 above which LV function deteriorated [as evidence by a 
decrease in EF, ESV, and cardiac output/work rate (CO/WR)].  He then expanded on this work 
in a group of patients with a history of myocardial infarction.
42
  Previous work had demonstrated 
a linear relationship between VO2 and WR (ΔVO2/ΔWR) in normal, healthy subjects and a 
reduction of this slope in those with CAD.  While Koike failed to confirm this finding; he did 
report a flattening of the slope of both CO/WR and CO/VO2.  The explanation offered was that 
an increase in oxygen extraction might be able to explain the preservation of the ΔVO2/ΔWR 
slope.  On the other hand, only LV dysfunction could explain the decrease in ΔCO/ΔVO2 above 
the anaerobic threshold.   
Koike
43
 further contributed to this body of literature with a study demonstrating 
important differences in the oxygen uptake kinetics in patients with prior MI.  Oxygen uptake 
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kinetics refers to the speed at which VO2 increases when exercise is initiated.  Faster kinetics is 
indicative of a healthier cardiovascular system.  Koike showed that prolonged kinetics is directly 
related to low cardiac output in patients with LV dysfunction.   
In the mid-late 1990’s several more researchers began focusing on this question.  In 1995 
Meyer et al
44
 compared the ischemic and ventilatory threshold (VT).  The ischemic threshold 
(IT) is the point at which ST segment changes and/or angina appears during exercise whereas VT 
is the point where there is an increased reliance on anaerobic metabolism.  The study confirmed 
the earlier findings about the appearance of ventilatory markers occurring prior to ECG markers 
of ischemia.  However this paper disputes the conclusion that the ventilatory changes are 
reflective of central, or left ventricular, origin and proposes that it is the peripheral contribution 
to exercise capacity that determined the shift toward a higher reliance on anaerobic metabolism.  
To support this they administered isosorbide dinitrate and found no changes in VO2, O2 pulse, 
lactate, HR or rate pressure product at the VT.  On the other hand, at the IT, all of these variables 
were significantly improved.  The authors explain this by suggesting the patients were 
deconditioned due to their disease and/or sedentary lifestyle.   
Klainman et al
45
 continued on in relating ventilatory variables to LV function in a study 
of patients with and without symptomatic ischemia (i.e. symptomatic vs. silent) but no previous 
history of MI or cardiac surgery.  This group was compared to a control group without ECG 
evidence of ischemia.  Several CPX variables were considered and LV function (via EF) was 
assessed with multigated acquisition radionuclear angiography (MUGA), the gold standard 
assessment for determination of EF.  VO2max and O2-pulse were lower in both ischemic groups 
(symptomatic and silent) compared to the controls.  These two variables were also significantly 
lower in the symptomatic ischemia group compared to the silent ischemia group.  Moreover, in 
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the symptomatic ischemia group there was a significant reduction in EF during exercise however 
in both other groups the EF increased.  This study offers support not only to the correlation 
between LV function and CPX variables but also to the belief that in non-diabetics silent 
ischemia represents less significant disease.   
An important contribution to this growing body of literature was made by an 
investigation reporting on the link between diastolic dysfunction and exercise capacity.
46
  In a 
group of patients with known CAD whose chief complaint was dyspnea it was demonstrated that 
at peak exercise the time-to-peak filling was significantly increased and correlated with exercise 
capacity (VO2max).  The authors posit that diastolic dysfunction could lead to systolic dysfunction 
accounting for the reduced cardiac output demonstrated in earlier studies. 
Another paper from Klainman’s lab47 reported on 50 patients with CAD without a 
previous history of myocardial infarction who underwent a CPX followed by a myocardial 
perfusion study (ECG-gated SPECT) to determine the relationship between extent of ischemia 
and aerobic capacity.  In it, patients with global ischemia <20% were significantly different than 
those at levels >20% in terms of VT, maximal work load achieved, max predicted HR, percent 
predicted VO2, VO2max and ΔVO2/ΔWR, despite no differences in number of stenotic arteries, 
extent of ST depression or presence of angina.  The only SPECT markers that were significantly 
different between the two groups (<20% vs >20%) were increase pulmonary uptake and transient 
ventricular dilatation, both of which the authors note are consequences of exercise-induced 
ischemia.   
Bigi et al
48
 used estimates of CO and measured VO2 to identify a cut point able to 
discriminate between those with and without CAD.  Sensitivity, specificity, negative and positive 
predictive value were all improved upon by the analysis of CPX variables [CO at ventilatory 
19 
 
threshold (COVT), to be specific] vs. ECG changes.  Moreover, three CPX variables (COVT, VO2 
at VT and peak VO2) were shown to be prognostic of future adverse cardiac events in the same 
patient population.   Furthermore, a cut off value of 7.3 L/min for COVT predicted improved 
survival whereas the same was not true for the presence or absence of ECG changes.   
Starting in the 2000’s focus began to shift to specific CPX variables, in particular O2-
pulse and the slope of ΔVO2/ΔWR, in detecting myocardial ischemia.  Specifically, Klainman
49
 
attempted to create a scoring system for the common changes seen in the behavior of the O2-
pulse during exercise in those with and without ischemia.  O2-pulse behavior was observed for 
normal linearity, flattening or decreasing slope during exercise.  Using this scoring system, it 
was possible to distinguish between CAD patients with or without impaired LV function as 
quantified by MUGA.   
Belardinelli et al
50
 prospectively studied a large group of patients with confirmed CAD 
and compared the results of CPX and ECG to SPECT.  By logistic regression the independent 
predictors of a positive nuclear perfusion study were duration of O2-pulse flattening and 
flattening of the slope of ΔVO2/ΔWR.  The addition of both of these positive findings 
significantly improved the sensitivity and specificity of the ECG findings.  Importantly, the 
addition of CPX helped to rule out ischemia in a significant portion of individuals for whom the 
ECG was falsely positive.  False positive ECG findings are especially problematic because they 
are more prevalent in women and because of the additional expense and risk incurred by 
additional testing.  Bussotti failed to confirm these O2-pulse findings but did affirm that a 
flattening of ΔVO2/ΔWR relationship in addition to low VO2 values at both the VT and IT as 
being suggestive of myocardial ischemia.
51
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Munhoz et al
52
 attempted to validate the findings regarding O2-pulse in a mode-
independent manner.  That is, most of the previous investigations had been performed on a 
bicycle ergometer and it was unknown if the phenomenon would remain diagnostic if the CPX 
was conducted on a treadmill.  All patients had a history of diagnosed CAD.  Oxygen pulse was 
assessed as an absolute value and compared in the group with ischemia vs. without and a 
separate comparison was made in a group with mild vs. extensive ischemia.  Only in the 
confirmed ischemia group was a significantly lower O2-pulse observed.   
 
Studies Evaluating CPX Variables after Coronary Intervention 
Several studies starting in the late 1980’s evaluated the effect of percutaneous 
transluminal coronary angioplasty (PTCA) on the CPX response.  Ajisaka et al
53
 demonstrated a 
significantly increased VE/VCO2 slope above the respiratory compensation point (i.e. the 
anaerobic threshold) between patients with CAD with normal EF and controls.  The minute 
ventilation/carbon dioxide production (VE/VCO2) slope improved (i.e. was reduced) after 
intervention with PTCA but only in patients for whom the PTCA was successful.  In those with 
failed PTCA, the VE/VCO2 slope actually increased further, suggesting these patients were 
suffering worsening cardiac function.  Klainman et al
54
  reported on 29 patients who performed a 
CPX before and after PTCA, after which significant improvements were noted in O2-pulse, VO2, 
O2-pulse score and the ventilatory anaerobic threshold.  Adachi et al
55
 reported a significant 
reduction in the time constant of VO2 kinetics following PTCA.  The oxygen kinetic response 
has been linked to cardiac output and the authors argue that an improved time constant is due to 
the improved cardiac output following intervention.  For patients with failed PTCA, the speed of 
the O2 kinetic response was no different than at their first CPX.   Most recently, Inbar et al
56
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confirmed these findings.  Two groups were compared, the first of which underwent PTCA while 
none of the second did.  All subjects performed a CPX twice.  Only in the intervention group did 
peak VO2, VO2 at VT, peak O2-pulse, and the O2-pulse slope improve significantly.  Moreover, 
the diagnostic accuracy of CPX to demonstrate this change was superior to ECG.   
Two single patient case studies of right coronary artery disease reported the findings of a 
significant flattening in O2–pulse and the ΔVO2/ΔWR relationship which normalized after 
PTCA.
57, 58
 
 
Studies Evaluating CPX Variables after Pharmaceutical Intervention 
Finally, several investigators are beginning to use CPX variables to demonstrate 
improved LV function following pharmaceutical intervention.  For example, the mechanism of 
action for trimetazidine is a shift is substrate utilization toward glucose and away from fatty 
acids, which would be beneficial to myocardium facing an O2 supply-demand mismatch.  This 
shift enables a higher yield of ATP for oxygen consumption and results in improved contractility 
without an effect on heart rate or blood pressure.  In patients with ischemic cardiomyopathy, 
trimetazidine has been shown to improve LV function, as demonstrated by improvements in peak 
VO2, without hemodynamic effects.
59
  Further, the addition of this drug potentiates the effect of 
exercise in a group of patients with ischemic cardiomyopathy.
60
  Similarly, pyridostigmine 
bromide, a cholinesterase inhibitor had a positive effect on exercise capacity as demonstrated by 
a delay in the onset of ischemia, increased peak VO2 and peak O2 pulse.
61
  Lastly, the effect of 
coenzyme Q10 (CoQ10) on cardiovascular function and CPX variables has been investigated.
62
  
CoQ10 has been demonstrated to be an antioxidant, have the ability to improve mitochondrial 
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bioenergetics and counteract endothelial dysfunction.  In CoQ10 supplemented patients peak VO2 
and O2-pulse were improved versus controls.   
 
Gaps in the Literature 
As is demonstrated by the progression and scope of these studies CPX variables 
accurately reflect LV function and furthermore, specific and predictable changes to CPX 
variables are indicative of EIMI.  Despite this body of promising preliminary evidence, the 
question remains if CPX can be used clinically to improve the diagnostic accuracy of the 
standard ECG exercise test for the purpose of ensuring the appropriate follow up.  In other 
words, can the addition of ventilatory gas analysis result in fewer patients undergoing 
unnecessary diagnostic tests?  Beyond that, it will take additional research to determine if this 
approach is cost effective, resulting in better outcomes for patients.   
Reducing work-up bias is a requirement for the evaluation of diagnostic tools but this is 
often overlooked in the methodologies of many studies.
63
  Work up bias underestimates the 
specificity and overestimates the sensitivity.  In many of the studies evaluating CPX the subjects 
had a previous diagnosis of coronary artery disease.  To establish the diagnostic utility of CPX it 
will be important to validate these findings in a population of all subjects with undiagnosed 
CAD.   
Furthermore, many of the studies described above used a bicycle ergometer as the mode 
of exercise, the more common mode in non-US countries.  Additionally, the analysis of some of 
the CPX variables differs depending on the mode, requiring adjustments to be made.  It must be 
demonstrated that the adjusted variables are also changed predictably in subjects who develop 
EIMI.   
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Lastly, a limited number of variables have been investigated, relative to those that can be 
obtained from a CPX, such as VE/VCO2 slope and the partial pressure of end-tidal carbon 
dioxide (PETCO2).  Only one study reported on the changes in VE/VCO2 slope induced by 
ischemia
53
 and none have considered PETCO2.  There is good reason to believe that these 
variables will also change as ischemia brings on LV dysfunction and cardiac output decreases.  
For example, PETCO2 is defined as the partial pressure of CO2 at the end of exhalation and 
reflects the heart’s ability to deliver deoxygenated blood back to the lungs.  Indeed, in patients 
with heart failure, PETCO2 is predictably low during exercise and at rest as one would expect 
with reduced CO.
64, 65
  One would expect to see a normal rise in PETCO2 followed by a decrease 
as the ischemic threshold is reached.   
 
Conclusion 
 There are currently many commonly used tools to diagnose CAD and each has excellent 
diagnostic accuracy with sensitivities and specificities in the range of approximately 80-90%.  
The newest tests which are not yet incorporated into clinical practice to the same extent, such as 
cardiac MR or CT, incrementally improve upon this already impressive record.  However, they 
do very little to reduce cost or chance of adverse event.  In other words, there already exist many 
tests which all provide approximately the same information with the same or similar level of risk.  
What would be especially useful is improving on the accuracy of the inexpensive non-invasive 
test in order to direct patients to the next level of care more effectively.  This is the potential role 
for CPX as it adds only incrementally to the cost but provides a substantial improvement in the 
accuracy of the common ECG exercise test.  Furthermore there is the added benefit of obtaining 
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prognostic information and the opportunity to begin patient education regarding the importance 
of exercise.   
Currently chest pain represents only 5% of the referrals for CPX and the barriers to fully 
integrate it into the routine diagnostic work-up of suspected CAD are significant.
66
  Clearly more 
studies validating and expanding on the work that has already been done are needed.  This 
additional research will support overcoming another impediment which is reimbursement from 
3
rd
 party payors such as Medicare.  The use of CPX in the assessment of patients with heart 
failure is currently reimbursable, explaining in part its greater incorporation into clinical practice 
in this chronic disease population.   
In order to realize the full potential of CPX the following recommendations are provided:  
1) validate the findings of the preliminary investigations in a larger population of patients 
without work up bias 2) investigate other ventilatory markers of ischemia that may improve 
further on its diagnostic accuracy and 3) conduct a longitudinal study to evaluate the cost 
effectiveness of using CPX in the initial diagnosis of CAD. 
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Table 1: American College Of Cardiology/American Heart Association Guidelines For 
Cardiopulmonary Exercise Testing (Adapted from ATS/ACCP Statement on 
Cardiopulmonary Exercise Testing)
67
 
Class (Indication) 
I (indicated)  
 Evaluation of exercise capacity and response to treatment in patients with heart failure who 
are being considered for heart transplantation  
 Assistance in the differentiation of cardiac versus pulmonary limitations as a cause of 
exercise-induced dyspnea or impaired exercise capacity when the cause is uncertain 
IIa (good supportive evidence) 
 Evaluation of exercise capacity when indicated for medical reasons in patients for whom the 
estimates of exercise capacity from exercise test time or work rate are unreliable 
IIb (weak supportive evidence) 
 Evaluation of the patient’s response to specific therapeutic interventions in which 
improvement of exercise tolerance is an important goal or end point 
 Determination of the intensity for exercise training as part of comprehensive cardiac 
rehabilitation 
III (not indicated)  
 Routine use to evaluate exercise capacity 
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Table 2: Absolute and Relative Contraindications to Maximal Exercise Testing
68
 
Absolute 
 Acute myocardial infarction 
 High-risk unstable angina 
 Uncontrolled cardiac arrhythmias causing symptomatic or hemodynamic compromise 
 Symptomatic severe aortic stenosis 
 Uncontrolled symptomatic heart failure 
 Acute pulmonary embolus or pulmonary infarction 
 Acute myocarditis or pericarditis 
 Acute aortic dissection 
Relative 
 Left main coronary stenosis 
 Moderate stenotic valvular heart disease 
 Electrolyte abnormalities 
 Severe arterial hypotension 
 Tachyarrhythmias or bradyarrhythmias 
 Hypertrophic cardiomyopathy and other forms of outflow tract obstruction 
 Mental or physical impairment leading to inability to exercise adequately 
 High degree atrioventricular block 
  
 
Table 3:  Common Variables Assessed with CPX and their Physiological Significance 
NON-VENTILATORY GAS VARIABLES ASSESSED WITH CPX AND 
PHYSIOLOGICAL SIGNIFICANCE 
VARIABLE DEFINITION AND 
PHYSIOLOGICAL 
SIGNIFICANCE 
NORMAL RESPONSE ABNORMAL RESPONSE 
Heart 
Rate 
The heart rate response to 
exercise is due to the 
autonomic nervous system.  At 
rest the heart is under 
parasympathetic  control.  An 
increase in heart rate requires 
the the addition of sympathetic 
input.  The return of heart rate 
to the resting value requires a 
reversal of this process.  
Cardiovascularly fit 
individuals are able to achieve 
a higher percentage of their 
age predicted maximum heart 
rate.   
   
A failure to achieve >85% 
maximum predicted HR, called 
chronotropic incompetence (CI), 
may be the result of ischemic 
limitation.  Impaired autonomic 
function has been implicated in CI 
and prolonged heart rate recovery 
is consistently shown to be an 
indicator of poor prognosis.   
Systolic 
BP 
During exercise, systolic blood 
pressure (SBP) rises due to the 
increase in stroke volume and 
cardiac output.   The strong 
muscular wall of the aorta into 
which the volume is being 
ejected has a constraining 
influence on cardiac output. 
SBP increases with increasing 
work load during exercise and 
often returns to below 
baseline values for several 
hours following the cessation 
of exercise.  
A blunted SBP increase is 
associated with cardiovascular 
disease, in particular CAD and 
heart failure, and confers poor 
prognosis.  A decrease from 
baseline in SBP is associated with 
cardiovascular disease.  Although 
CAD is often the cause, other 
explanations include peripheral 
vasodilation and mitral 
regurgitation.  
Diastolic 
BP 
Diastolic BP (DBP) is 
correlated with total peripheral 
resistance (TPR), which is the 
total resistance in the arterial 
system.   
During exercise, DBP remains 
stable or decreases slightly 
due to the opposing influences 
of local muscle vasodilation 
and cardiac output. 
 
A significant increase in DBP is 
associated with myocardial 
ischemia or may be a marker for 
labile hypertension, a risk factor 
for CAD development.   
 
Dyspnea Dyspnea is shortness of breath 
or increased work of breathing.  
Its physiological significance 
in heart disease is debated but 
may be related to systolic or 
diastolic dysfunction, ischemia 
or abnormal peripheral 
vascular tone.   
Dyspnea can be a normal 
physiological consequence of 
heavy exertion, but it usually 
not exercise-limiting. 
 
In one study of nearly 18,000 
patients dyspnea, in the presence or 
absence of CAD and/or angina, 
was prognostic of future mortality 
from cardiac and non-cardiac 
causes.
69
    
Angina Chronic stable angina is the 
most common symptomatic 
manifestation of obstructive 
CAD.  However, clinically 
significant CAD may be 
present in a patient not 
experiencing angina (so-called, 
silent or asymptomatic 
ischemia.)   Causes of angina, 
other than CAD, are however 
numerous.   
 
  None 
 
Typical angina is pressure, 
tightness, and/or diffuse pain 
located substernally, is centered in 
the neck or radiates down the left 
arm.  It comes on with exertion and 
abates with rest.[16]  In one study, 
72% of the patients studied who 
developed chest pain with exercise 
but no ST segment changes had 
significant CAD identified 
angiographically.
70
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VENTILATORY GAS VARIABLES ASSESSED WITH CPX 
VARIABLE DEFINITION AND 
PHYSIOLOGICAL 
SIGNIFICANCE 
NORMAL RESPONSE ABNORMAL RESPONSE 
VE Minute ventilation (VE) is the 
volume (in liters) of air moving 
into and out of the lungs per 
minute and is the product of the 
respiratory rate and the volume of 
air exhaled with each breath, 
which generally is the same as the 
volume inhaled.   
At rest, the respiratory rate is the 
primary determinant of VE.  
During exercise VE is augmented 
by an increase in tidal volume.   
 
The ventilatory equivalent for O2 
(VE/VO2) and CO2 (VE/VCO2) are 
often assessed and show characteristic 
changes in response to pathological 
states (see section below for more 
information on VE/VO2 and 
VE/VCO2.) 
Anaerobic/ 
Ventilatory 
Threshold 
Ventilation is driven by CO2 
levels.  When cellular respiration 
is being primarily carried out 
aerobically, VE increases in near-
perfect concert to allow for the 
elimination of the CO2.  As the 
contribution of anaerobic 
metabolism increases, ventilation 
will increase non-linearly to expel 
the additional CO2 produced that 
cannot be buffered.  This is called 
the anaerobic or ventilatory 
threshold (AT or VT). 
A plot of ventilation and CO2 
production is linear below the 
AT/VT. Once this threshold is 
achieved, a steep increase in the 
slope of the line is noted.  
Beyond this threshold, exercise 
can only be maintained for a 
short period of time before 
reaching a maximum.  A greater 
workload at a given anaerobic 
threshold is indicative of a fitter 
individual.   
In less fit individuals and those with 
cardiovascular or pulmonary disease 
the AT will be reached at a lower 
workload.  Clinically, the 
hemodynamic status of the patient at 
AT/VT has been shown to be 
important and clinical improvement 
often results in improvements in these 
values.   
VO2 VO2 is the amount of O2 removed 
from the inspired air, as it 
performs work.  It is a direct 
measurement of aerobic exercise 
capacity.   VO2 has both central 
and peripheral components.  
Increases in VO2 are explained 
primarily by increases in cardiac 
output.  
In normal, non-diseased 
individuals, the cardiovascular 
system is the limiting factor to 
VO2.  That is, increases in VO2 
are limited by the heart’s ability 
to deliver oxygen to the working 
muscles and not the lung’s ability 
to participate in gas exchange.  
Absolute VO2 is dependent 
primarily upon age and gender.   
Reductions in exercise capacity are 
commonly seen in many diseases of 
the cardiovascular and pulmonary 
systems, as well as in those with 
general deconditioning due to 
sedentary lifestyle or chronic illness. 
In particular, a reduced peak or max 
VO2 is associated with poor 
prognosis.
71
   
Oxygen 
Pulse 
Oxygen pulse (VO2/HR) is an 
indirect measure of stroke volume  
 
Under normal physiological 
conditions, O2-pulse increases 
linearly with exercise and 
promptly falls upon cessation of 
exercise.   
Several investigators have 
demonstrated a plateau or flattening of 
O2-pulse in patients who develop 
myocardial ischemia during exercise.  
See Figure 2. 
Respiratory 
Exchange 
Ratio 
The respiratory exchange ratio 
(RER) is the ratio of VCO2 to 
VO2.   At rest the body is utilizing 
(i.e. converting to CO2) 75% of 
the oxygen it brings in, depending 
on the substrate being consumed.  
The RER for the complete 
oxidation of a carbohydrate is 1.0.  
As lipids are utilized the RER 
decreases because fats require 
more oxygen to be fully 
metabolized.   
 
As exercise progresses, the 
production of CO2 surpasses 
oxygen uptake and RER will 
exceed 1.0.[73]  Although many 
factors contribute to RER this 
variable is the single best 
indicator of subject effort with a 
value ≥1.10 indicated maximal 
exertion.
72 
A failure to achieve an RER value of 
greater than 1.0 may be associated 
with pulmonary or cardiovascular 
disease, including deconditioning, or 
poor effort.  It also may be related to 
the nutrient content of a meal eaten 
just prior to the CPX.   
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PETCO2 PETCO2 is the highest alveolar 
PCO2 during the respiratory 
cycle.  It is reflective of the 
heart’s ability to deliver 
deoxygenated blood from the 
right side of the heart to the 
lungs.  PETCO2 also indicates 
physiological pulmonary dead 
space.  That is, the mismatch 
between alveoli either un- or 
under-perfused or 
unventilated.  
 
The normal range is from the 
upper 30s to mid/upper 40s in 
mmHg.  A normal increase in 
PETCO2 from rest to VT is 3-8 
mmHg 
A lower than normal value would 
be indicative of a reduced cardiac 
output or a ventilation-perfusion 
mismatch. PETCO2 is correlated 
with cardiac output and is of 
prognostic utility in the assessment 
of patients with heart failure and 
pulmonary hypertension.
64, 73-75
   
ΔVO2/ΔWR The slope of VO2 as a function 
of work rate is a measure of 
efficiency.  Smaller changes in 
VO2 for equal changes in work 
rate indicate a greater 
efficiency (consumption of 
less oxygen for greater work), 
resulting in a smaller value of 
ΔVO2/ΔWR.   
In highly trained individuals 
the slope of  ΔVO2/ΔWR is 
higher compared to a less-fit 
person.  VO2 typically 
increases linearly with 
increasing work rate.  Above 
the anaerobic threshold the 
slope may be shallower 
owing to the decreased 
reliance on oxygen for the 
performance of work.    
Changes to the  ΔVO2/ΔWR slope 
can be the result of peripheral or 
central dysfunction.   A drastic 
change in VO2 is most often 
reflective of a change in cardiac 
output since it is the primary 
determinant of VO2.  Peripherally, 
oxygen extraction can also be 
compromised although acute 
changes are less common. See 
Figure 3.   
 
 
VE/VCO2 The VE/VCO2 relationship 
reflects the ventilation required 
to expel a certain quantity of 
CO2.  This can be expressed as 
a ratio or a slope but the latter 
is preferred. 
 
At sub-maximal exercise VE 
and VCO2 closely mirror each 
other but the ratio does not 
increase much during sub-
maximal exercise owing to the 
fact that ventilation easily 
keeps pace with metabolically 
created CO2.  At the 
ventilatory threshold CO2 is 
produced in greater quantity 
and in normal subjects VE 
will increase non-linearly to 
keep pace.  
The VE/VCO2 slope has been 
demonstrated to be elevated in 
individuals with heart failure.
76-79
  
There is some evidence it may be 
abnormal in patients with exercise 
induced myocardial ischemia.
53
   
VE/VO2 
or OUES 
The VE/VO2 relationship 
reflects the ventilation per 
quantity of oxygen consumed.   
 
OUES, the slope of the 
logarithmic regression curve 
expressing the relation between 
VO2 and VE represents the rate 
of increase in VO2 in response 
to a given VE.  A steeper slope 
would be indicative of a greater 
uptake of oxygen in response to 
a given ventilatory rate.
80
   
 
The normal range for the 
VE/VO2 slope is 30-40.  In 
highly trained individuals 
baseline VE/VO2 is lower 
owing to greater efficiency, 
i.e. more oxygen being 
consumed with less 
ventilatory work.  During 
exercise, VE/VO2 decreases 
until the ventilatory threshold, 
when ventilation increases 
significantly in an effort to 
expire additional non-buffered 
CO2.  
Baseline OUES is elevated in 
patients.
81
   
 
OUES in patients is lower than in 
apparently healthy individuals.  A 
review comparing the OUES to the 
VE/VCO2 slope in the heart failure 
patient population revealed the 
superiority of the VE/VCO2 slope 
in predicting adverse events.
82  
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TABLE 4:  SUMMARY OF DIAGNOSTIC ACCURACY. RISKS,  LIMITATIONS  OF COMMON TESTS 
TO DIAGNOSE CAD 
Test  Sens Spec PPV NPV Risks Limitations 
Cardiac 
Angiography/ 
Catheterization 
 - Death, MI, CVA: 
0.2% - 0.3%  
- Minor 
complications (e.g. 
hematoma at 
catheter site): 1% - 
2%
83
 
- Hemodynamic 
complications: 
0.26%
84
 
- Risks related to 
radiation exposure  
- Dyes may be 
problematic due to 
allergies or co-
morbidities  
- Not a functional 
assessment; does 
not fully capture 
clinical significance 
of stenosis 
- Limited use in 
microvascular CAD 
- May not correlate 
well with function 
- Negative result is 
not definitive proof 
of absence of 
CAD
38
 
CPX 
 
87%
50
 74% 88% 72% - Serious adverse 
events (MI or 
hospitalization): 
<1-5 per 10,000 
tests 
- Death: 0.5 per 
10,000 tests
85
 
- If positive, further 
testing is needed to 
determine which 
vessels are involved 
 
Ex ECG
31
 
All 
Only women 
 
23-00%  
Compar-
able 
 
17-100% 
Lower 
 
NR 
 
NR 
 
Same as above - False positives are 
common and 
significant among 
women and those 
with baseline ECG 
abnormalities
16
 
MPI
86
 
 Non-Ex 
Exercise 
 
 
72-93% 
71-97% 
 
 
28-100% 
36-100% 
 
NR 
 
NR 
- Risks related to 
exercise, same as 
above 
- Risks related to 
myocardial 
perfusion study 
include exposure 
to radioactive 
tracer 
- Diagnostic 
accuracy impacted 
if > 85% HR target 
not achieved
87
 
Ex Echo
88
 
All 
+ Referral 
Bias 
 
 
71-97% 
32-93% 
 
 
41-100% 
37-100% 
 
71-100% 
66-100% 
 
40-93% 
54-90% 
- Risks related to 
exercise, same as 
above 
 
- Diagnostic 
accuracy impacted 
if > 85% HR target 
not achieved
89
 
- Resting wall 
motion 
abnormalities make 
interpretation 
difficult
90
 
- Difficult to 
determine site of 
disease
33
 
31 
 
 
MR
83
 
CAD 
CABG 
patency 
 
50-94% 
73-100% 
 
42-100% 
40-100% 
 
NR 
 
71-96% 
 - Spatial resolution is 
lower vs 
angiography and 
CT 
- Relative imaging 
time (vs MPI) is 
longer 
- Software and 
hardware may not 
be widely available 
- Metal medical 
devices are a 
contraindication 
- Claustrophobia 
- No data on 
improved outcomes  
 
CT
83
 
CAD 
 
 
 
30-100% 
 
 
 
 
9-99% 
 
 
 
 
 
NR 
 
83-100% 
- Radiation dose 
- IV administration 
of contrast medium 
can lead to allergic 
reaction or adverse 
events related to 
kidneys, especially 
in those with 
compromised renal 
function 
 
- Relative imaging 
time (vs MPI) is 
longer 
- May be necessary 
to 
pharmacologically 
reduce HR 
- No data on 
improved outcomes 
 
Abbreviations: Ex = exercise, sens = sensitivity, spec = specificity, PPV = positive predictive value, NPV = negative 
predictive value, NR = not reported, MR = magnetic resonance, CT = computed tomography, occl = occlusion, sten 
= stenosis, CAD = coronary artery disease, CABG = coronary artery bypass graft, CPX = cardiopulmonary exercise 
test  
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Table 5: Chronological Summary of Studies Using CPX in Suspected or Confirmed 
Myocardial Ischemia 
Author Year 
# of 
Subjects/Cardiac 
History 
Gold 
Standard/Tests 
Compared Significant Findings 
Ehsani
40
 1984 27 asymptomatic 
patients (26 men) with 
CAD, all with prior MI 
- EF determined by 
MUGA 
- VO2max was significantly lower in 
those whose EF decreased with 
exercise 
- Max O2-pulse in subjects with 
decreased EF during exercise was 
lower vs those whose EF 
increased with exercise 
- ΔEF (exercise – rest),  was 
significantly correlated with 
VO2max, O2-pulse 
- ΔEF, HRmax were the best 
predictors of VO2max 
- VO2max ~22% lower in patients 
with reduced EF during exercise 
 
Koike
41
 1989 23 patients with heart 
disease (ischemic or 
valvular) 
- None - AT correlated with work rate at 
which LV dysfunction occurred  
 
Koike
42
 1992 22 patients (19 men) 
with previous MI 
- Cadmium telluride 
detector for EF 
- VO2/WR slope no different above 
and below AT 
- CO/WR slope significantly 
different (lower above the AT vs. 
above) 
- CO/VO2 was also significantly 
different (lower above vs below 
AT) 
 
Koike
43
 1994 - 43 asymptomatic 
patients (36 men) with 
previous MI; 2 
groups: 
- Group I: (n=20) EF 
> 35% 
- Group II: (n=20) EF 
< 35% 
- Cadmium telluride 
detector for EF 
- Angiography to 
detect stenotic 
vessels 
- Delayed time constant of VO2 
evident in patients with LV 
dysfunction (EF < 35%) 
- Time constant for CO was longer 
in patients with LV dysfunction 
- SV, HR  increase impaired in 
subjects with EF <35% 
 
Meyer
44
 1995 27 (all male) patients 
with CAD, 16 with 
previous MI; a second 
group of 10 patients 
with CAD received 
isosorbide dinitrate 
(ISDN)  
- None - AT preceded ST segment changes 
indicative of ischemia and was 
associated with a lower WR, RPP, 
VO2, lactate, HR 
in the 2
nd
 group of patients, after 
ISDN administration, the onset of 
ischemia occurred at a greater 
workload, VO2 and lactate level; 
no changes to AT  
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Ajisaka
53
 1996 - 22 patients (17 men) 
with CAD performed 
CPX before and after 
PTCA 
- EF determined by 
echocardiography 
- stenosis 
determined by 
angiography 
- Significant differences between 
subjects with s 
- Successful PTCA vs failed PTCA 
- VE/VCO2 slope, peak VO2 and 
VO2 at VT improved in successful 
PTCA group; worsened in failed 
PTCA group 
 
Klainman
45
 1996 - 58 patients with 
suspected CAD;  3 
Groups: 
- Group I: no ST 
segment changes/no 
angina 
- Group II:ST 
segment changes 
only (silent) 
- Group III: ST 
segment changes 
and angina  
 
- EF determined by 
MUGA 
- Angiography 
performed only in 
symptomatic or 
silent groups  
- O2-pulse higher in patients with 
ST segment changes but no 
angina vs ST segment changes 
with angina 
- EF declined during exercise in the 
symptomatic group and increased 
only slightly in the silent ischemia 
group 
- No significance difference in # of 
vessels affected between silent 
and symptomatic groups  
Lele
46
 1996 - 20 patients (15 male) 
with CAD compared 
to 10 healthy controls 
(8 males) 
- EF and diastolic 
function by 
MUGA 
- MPI to detect 
reversible 
perfusion defects 
- CAD confirmed 
by angiography 
prior to CPX 
 
- Significant negative correlation 
between diastolic function during 
exercise (time to peak filling) and 
VO2max 
Hsi
91
 1997 - 43 post MI patients 
- 43 trained men 
- 44 untrained men 
- EF determined by 
MUGA 
 
 
- Low O2-pulse/body weight 
significantly associated with LV 
dysfunction and ischemia during 
exercise 
Klainman
54
 1998 - 29 patients (36 
males) with CAD 
performed CPX 
before and after 
PTCA 
- Coronary 
angiography for 
determination of 
stenotic vessels 
before CPX 
 
- All patients with successful PTCA 
had improvements in VO2max, O2-
pulsemax, O2-pulse curve score, 
AT 
Zafrir
47
 1999 50 patients (49 men) 
classified as having </> 
20% ischemia 
- MPI for % 
ischemia 
determination 
- VO2 and extent of myocardial 
ischemia were significantly 
negatively correlated 
- More ischemia (vs. less) 
associated with significantly 
lower ΔVO2/ΔWR, VT 
- VT was the most sensitive 
predictor of % ischemia 
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Adachi
55
 2000 17 male patients with 
CAD all of  whom had 
PTCA 
- Coronary 
angiography for 
stenotic vessels 
- Time constant of VO2 uptake 
shorter after PTCA, except in 
those who had a failed PTCA 
- Absolute VO2 values were no 
different before vs after PTCA in 
either successful or failed PTCA 
patients 
 
Belardinelli59 2001 38 patients (31 males) 
with CAD and LV 
dysfunction; 2 groups, 
one receiving 
trimetazidine and the 
other a placebo 
- Echocardiography 
for EF, diastolic 
function, systolic 
wall thickening, 
LV wall motion 
- VO2peak improved in treatment 
group with no significant changes 
in hemodynamic variables 
- Contractile improvement 
demonstrated in the treatment 
group correlated with 
improvements in VO2peak 
 
Bigi
48
 2001 46 patients (39 males) 
with anterior 
myocardial infarction 
and LV dysfunction 
- Coronary 
angiography to 
determine stenotic 
vessels 
- EF determined by 
MUGA 
- ECG for 
determination of 
myocardial 
ischemia (based on 
ST segment 
change) 
- COAT  in those with ECG changes 
lower than in those without 
- COAT value of 7.3 L/min was the 
best cutoff value for identifying 
those with multi-vessel CAD 
- ECG Sensitivity, Specificity, 
NPV, PPV: 64%, 43%, 57%, 
50%, respectively 
- COAT  Sensitivity, Specificity, 
NPV, PPV: 72%, 62%, 69%, 
65%, respectively 
- COAT  < 7.3L/min was predictive 
of future events and event-free 
survival 
 
Klainman
92
 2002 46 patients (39 males) 
with ischemic heart 
disease classified into 4 
groups based on resting 
EF, ΔEF with exercise, 
ECG changes indicative 
of diastolic dysfunction  
 
- EF determined by 
MUGA 
-  
- Significant negative correlation 
between LV function and O2-
pulse score (points system to 
classify behavior – normal, low, 
flat and low, declining) 
Belardinelli50 2003 202 patients (173 men) 
with CAD 
- MPI used as gold 
standard for 
ischemia detection 
- O2 pulse flattening duration and 
ΔVO2/ΔWR slope were predictive 
of ischemia 
- inclusion of O2-pulse flattening 
duration and ΔVO2/ΔWR slope 
improved the sensitivity and 
specificity of ECG from 46% to 
87% and 66% to 74%, 
respectively  
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Castro
61
 2004 15 patients (12 males) 
with CAD with 
exercise-induced 
myocardial ischemia 
underwent CPX before 
and after taking 
pyridostigmine or 
placebo, a 
cholinesterase inhibitor 
 
- None - VO2peak, VCO2, VE, O2-pulse 
were all improved after 
pyrostigmine administration vs. 
placebo and delaying the onset of 
exercise induced myocardial 
ischemia and indicating the 
sensitivity of these variables to 
the consequences of ischemia 
Bussotti
51
 2006 48 patients with (n=35) 
and without (n=13) 
significant coronary 
lesions; all had 
asymptomatic ST 
segment changes 
indicative of ischemia 
 
- Coronary 
angiography for 
determination of 
stenotic vessels 
 
- % predicted VO2peak was 
significantly lower in those with 
significant coronary stenosis 
- ΔVO2/ΔWR slope was less steep 
in those with significant lesions vs 
those without 
Contini
57
 2006 Single subject case 
study 
- Cardiac CT 
angiography 
confirmed stenosis 
 
- Following PTCA O2-pulse, 
ΔVO2/ΔWR and VO2 normalized 
Munhoz
52
 2007 87 patients with 
suspected or confirmed 
CAD 
- MPI used as a gold 
standard to detect 
ischemia 
- No difference in CPX variables 
between patients presenting with 
vs without ischemia 
- Peak O2-pulse lower in subjects 
with extensive vs mild ischemia 
 
Tiano
62
 2007 38 patients (33 males) 
with CAD divided into 
two groups, one of 
which received 
Coenzyme Q10 (CoQ10) 
supplementation, the 
other did not 
- None - CoQ10 supplementation resulted 
in significant improvements in 
VO2peak, VO2AT, VE, O2-pulsepeak, 
ΔVO2/ΔWR, WRpeak, SBPpeak 
confirming the sensitivity of these 
variables to changes in LV 
function 
 
Belardinelli60 2008 116 patients (97 males) 
with ischemic heart 
disease, LV 
dysfunction; 4 groups 
were compared:  
I) trimetazidine + 
exercise 
II) exercise + placebo 
III) trimetazidine 
IV) Placebo + untrained 
 
- Echocardiography 
to detect diastolic 
and systolic 
function, and EF 
- Trimetazidine plus exercise 
resulted in the greatest gains in 
VO2, LV EF vs trimetazidine or 
exercise alone confirming the 
sensitivity of VO2 to 
improvements in LV function 
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Chaudhry
58
 2008 Single subject (male) 
case study 
- Coronary 
angiography to 
detect stenotic 
vessels 
 
- No ST segment changes 
indicative of ischemia 
- O2-pulse gradually decreased with 
increasing work rate, abrupt 
decrease in the slope of VO2/WR 
and an increase in the slope of 
HR-VO2 
 
Inbar
56
 2008 14 subjects (13 males) 
had cardiac 
catheterization; 8 went 
on to have PTCA, the 
other 6 did not; all 
underwent CPX  
- The ability of CPX 
to detect 
myocardial 
ischemia was 
compared to ECG  
- Pre-PTCA ECG specificity, 
sensitivity: 100%, 25%, 
respectively 
- Post-PTCA ECG specificity, 
sensitivity: 20%, 64%, 
respectively 
- Those with PTCA had significant 
improvements in VO2peak, VAT, 
O2-pulsepeak, and O2-pulse score 
vs those who did not undergo 
PTCA 
- CPX improved ECG sensitivity 
and specificity by 89% and 12%, 
respectively 
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FIGURE 1: OVERVIEW OF INSTRUMENTATION USED FOR CARDIOPULMONARY EXERCISE 
TESTING 
 
Legend for Figure 1 
 Metabolic Cart:  The subject breathes through a mouthpiece (with nose sealed off by a clip) 
or facemask.  Non-rebreathing valves are used to separate inspired and expired air.  Oxygen 
and carbon dioxide gas analyzers and sensors measure air flow over time and are used for 
volume measurements. Finally, ventilation, O2 consumption and CO2 production (all in 
L/min) are calculated via breath-by-breath techniques.  Continuous ECG monitoring and 
periodic recording of HR and BP are also standard and automated on most modern systems.
93
 
 Mode:  Treadmill or Bicycle  
 Workload Determination/Protocol:  Ideally, the functional capabilities of the subject 
determine the protocol used however in clinical practice the most often used is the Bruce 
Protocol.   
 Personnel: American Heart Association guidelines state clinicians present to supervise the 
test should have demonstrated competence in the area of exercise testing.  Those present 
should include at a minimum include a physician, nurse, exercise physiologist and/or 
physical therapist.
85
 
 Communication: Verbal communication is limited due to the facemask or mouthpiece and 
therefore prior to the test it is important to establish the use of hand signals or written signs 
that can be pointed to.   
 Variables/Measures: See Table 3 for full listing 
 Indications/Contraindications:  See Tables 1 and 2 for full listing  
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FIGURE 2: NORMAL AND ABNORMAL OXYGEN PULSE RESPONSE DURING PROGRESSIVE 
EXERCISE TESTING 
 
 
 
 
FIGURE 3: NORMAL AND ABNORMAL CHANGE IN OXYGEN CONSUMPTION/CHANGE IN 
WORKRATE RESPONSE DURING PROGRESSIVE EXERCISE TESTING 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter 2: Real-Time Decrease in the Oxygen Uptake Efficiency Slope Identifies 
Myocardial Perfusion Defects in Men Undergoing Ischemic Evaluation 
 
ABSTRACT 
Introduction: Cardiopulmonary exercise test (CPX) variables may aid in the diagnosis of 
coronary artery disease (CAD).  Specifically, an abnormal flattening or declining trajectory of 
the oxygen (O2) pulse has been shown to be predictive of the onset of myocardial ischemia in 
patients previously diagnosed with CAD.  However, a more heterogeneous clinical population 
without prior work-up bias has not been studied.  Moreover, additional CPX variables have not 
been assessed.  The purpose of the current investigation is to address these gaps in the literature. 
Methods: Three hundred and three subjects with symptoms suggestive of myocardial ischemia 
underwent CPX and single photon emission computed tomography (SPECT) myocardial 
perfusion study (MPS).   Ventilatory efficiency was calculated by the oxygen uptake efficiency 
slope (OUES).  The change in the OUES was calculated by subtracting the value of OUES 
during the last 25% (OUES75) of exercise from the OUES obtained during the first 50% 
(OUES50).  O2 pulse flattening duration was calculated by subtracting the total exercise time 
from the time at which the peak O2 pulse occurred.   
Results: A negative change in OUES was predictive of a positive MPS (area under receiver 
operating characteristic curve [AUC] = 0.59, 95% CI [0.52, 0.65], p = 0.02), and even more 
strongly so in those with a more a definitive (i.e. not equivocal) perfusion defect (AUC = 0.67, 
95% CI [0.57, 0.77], p <0.01).  A gender specific analysis revealed the diagnostic significance of 
the OUES was isolated to male subjects for both any level of positive MPS (AUC = 0.67 95% CI 
[0.59, 0.76], p <0.001) and more so in those with a more definitive perfusion defect (AUC = 0.76 
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95% CI [0.67, 0.85], p <0.001).  The predictive ability of O2 pulse could not be confirmed in the 
whole cohort; however, in males the change in O2 pulse from rest to peak was predictive of a 
mild-severe perfusion defect (AUC = 0.66, 95% CI [0.52, 0.80], p = 0.02).   
Conclusions: This is the first time that real-time change in ventilatory efficiency, assessed by the 
OUES, has been shown to be predictive of positive MPS and possible CAD.  Changes in the 
OUES only seem to provide diagnostic value in males when MPS is used as the gold-standard 
assessment. 
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Introduction 
Coronary artery disease (CAD) accounts for more than half of all cardiovascular events 
suffered by men and women under the age of 75 in the United States.  An estimated 7 million 
inpatient cardiovascular operations and procedures are performed each year. As a result, the 
diagnosis of CAD will have an estimated cost of $177.1 billion in 2010.
94
 The proliferation of 
diagnostic tests to detect CAD continues to expand, keeping pace with technological advances.  
Even so, the use of the traditional exercise test remains central to the assessment of patients with 
suspected CAD.  An area that has received relatively little clinical attention is the diagnostic 
utility of ventilatory gas analysis during the traditional exercise test.  Given the coupling of the 
cardiovascular and pulmonary systems during physical exertion, real-time abnormal alterations 
in ventilatory expired variables may be valuable in the diagnosis of CAD.  Research over the 
past 20 years has supported this premise.
95
   
Currently, cardiopulmonary exercise testing (CPX), the term used to describe the 
integration of ventilatory expired gas analysis and the traditional exercise test, is used to measure 
aerobic capacity directly, differentiate between cardiac and pulmonary causes of exertional 
dyspnea, assess prognosis in patients with heart failure
96
 and, more recently, to diagnose and 
gauge disease severity in  pulmonary hypertension.
97
  The rationale supporting the use of CPX in 
diagnosing CAD lies in its ability to detect real-time, abnormal alterations in ventilatory expired 
gas that may be reflective of the onset of ischemia-induced left ventricular (LV) dysfunction.   
Several CPX-derived variables have been identified as being indicators of LV 
dysfunction precipitated by myocardial ischemia.
95
  The oxygen (O2) pulse [oxygen 
consumption/heart rate (VO2/HR)], which follows a linear trajectory during a progressive 
exercise test, has been shown to abnormally flatten or decline in the presence of exercise induced 
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myocardial ischemia (EIMI).
50
  Similarly, the normally linear relationship between VO2 and 
work rate (WR), has been demonstrated to prematurely flatten in the presence of EIMI.
50
  
Strengthening these cross-sectional observations are studies demonstrating an improvement in O2 
pulse and the VO2-WR slope following successful percutaneous coronary intervention (PCI).
60, 62
   
  Two recent investigations have focused on the ability of CPX variables to detect EIMI.
50, 
52
  Belardinelli et al.
50
 prospectively studied 202 patients (86% male) with confirmed CAD and 
compared the results of CPX and the traditional exercise test variables, using a lower extremity 
(LE) ergometer as the mode of exercise, to myocardial perfusion studies.  By logistic regression, 
the independent predictors of a reversible perfusion defect were duration of O2 pulse flattening 
(measured as the time between the occurrence of maximum O2 pulse and total exercise time) and 
flattening of the VO2-WR slope.  When both of these CPX variables were positive, the 
sensitivity and specificity of the exercise test (i.e. ST segment changes) were improved by 89% 
(from 46% to 87%) and 32% (from 66% to 74%), respectively.  Munhoz et al.
52
 assessed the 
ability of O2 pulse to identify an abnormal myocardial perfusion study.  This was the first study 
which employed a treadmill instead of a LE ergometer.  This is clinically relevant given the 
former is the primary exercise mode utilized in exercise testing labs in the United States.  Of the 
87 patients (71% male) included in this analysis, 16 had a prior myocardial infarction, 49 had 
prior cardiac catheterization, 30 had undergone PCI and nine had coronary artery bypass surgery.  
All subjects underwent CPX followed by a myocardial perfusion study and were divided into 
two groups based on the presence or absence of ischemia.  Oxygen pulse at rest, 25%, 50%, 75% 
and peak VO2 was not different between the two groups.  However, in a separate comparison in 
which the ischemia group was divided into mild vs. extensive ischemia, O2 pulse at peak VO2 
was significantly lower in the latter.   
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While these initial investigations are promising, additional research is needed to more 
clearly elucidate the value of CPX in the evaluation of those with suspected CAD. Of the 
numerous questions that have not been answered, first, it remains to be determined if CPX will 
remain diagnostically accurate in an “all-comers” patient population.  To this point, research has 
included subjects who were either exclusively or predominantly diagnosed with CAD at study 
enrollment, introducing work-up bias as a potential confounding factor.  Several large studies 
confirm that in today’s clinical environment, the patient population referred for exercise testing 
is more heterogeneous, with the majority being low risk, presenting with signs and/or symptoms 
merely suggestive of CAD.
98, 99
  This illustrates the importance of the use of relatively 
inexpensive diagnostic tests to better identify those who require additional, often more costly, 
procedures.   
In addition, a comprehensive assessment of all potentially valuable CPX variables, 
beyond O2 pulse and VO2-WR slope, in the diagnosis of EIMI has not been performed.  For 
example, real-time abnormal changes in the trajectory of ventilatory efficiency may prove 
valuable.  The most common expressions of ventilatory efficiency are the minute 
ventilation/carbon dioxide (VE/VCO2) slope and the oxygen uptake efficiency slope (OUES).  
Both variables reflect the integrated function of the cardiac and pulmonary systems during 
physical exertion and are thus potentially valuable in the detection of the onset of ischemia-
induced LV dysfunction.  Moreover, variables reflecting ventilatory efficiency may have 
diagnostic advantages over the O2 pulse and VO2-WR slope.  For example, these variables may 
be less affected by the influence of treadmill hand rail use and pharmacologically-induced 
alterations in heart rate. Of the two common measures of ventilatory efficiency, the OUES holds 
particular promise given a normal response during progressive exercise follows a tight linear 
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trajectory.  Thus, even subtle negative deviations in this response may prove to be significant in 
detecting ischemia-induced LV dysfunction. Given these gaps in the literature, the objectives of 
the present study are to: 1) assess the diagnostic value of CPX in a group of subjects undergoing 
clinical assessment for CAD without prior work-up bias and 2) more comprehensively assess the 
utility of all relevant CPX variables in identifying reversible myocardial perfusion defects 
quantified by nuclear imaging.  
 
Methods 
The current investigation prospectively assessed 303 patients who presented to the Non-
Invasive Stress Laboratory of Virginia Commonwealth University Medical Center from May 
2009 to February 2010. Subjects presented with symptoms suggestive of myocardial ischemia 
and/or a previous history of CAD.  Common indications included chest pain (65.3%), dyspnea 
(8%), history of CAD (5%), syncope (1.3%), palpitations (3%) and/or abnormal ECG (2.4%).  
Exclusion criteria were myocardial infarction or PCI within three months of testing, previous 
diagnosis of congestive heart failure, known left ventricular ejection fraction <35%,  evidence of 
moderate lung disease by pulmonary function test, moderate or severe aortic or mitral valve 
stenosis, unstable angina or uncontrolled hypertension, previous pacemaker implant or coronary 
artery bypass grafting, orthopedic/neurologic conditions that limited exercise performance, 
and/or inability to collect interpretable ECG and nuclear imaging data.  The traditional cardiac 
risk factors, hypertension, lipid profile, tobacco use, family history of early coronary disease, 
physical activity and diabetes, were recorded.   Physical activity frequency, duration and 
intensity were measured by patient self-report.  Exercise tests were performed in the fasting state 
and patients were instructed to avoid all caffeine-containing food or drink in the 4 hours prior to 
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the test.  Patients were instructed to follow the recommendation of their physician on taking 
prescribed medications.  However, it was noted if the patient was taking a beta-blocker and if so, 
whether it was taken as prescribed on the day of the test.   
The protocol was approved by the Institutional Review Board at Virginia Commonwealth 
University.  All subjects signed an informed consent prior to inclusion in the study. 
 
Nuclear Myocardial Perfusion Imaging Procedures 
All subjects had the stress portion of a single photon emission computed tomography 
(SPECT) myocardial perfusion study (MPS) the same day as the standard exercise test with 
ventilatory expired gas analysis.  However, based on referral source and/or patient 
characteristics, some subjects underwent the rest portion of the MPS on a different day.  Two 
main referral sources exist for this clinic.  The first is the Emergency Department (ED) from 
which patients are referred for follow up stress MPS after undergoing an evaluation for possible 
myocardial ischemia or infarction.  At the time of the ED visit patients undergo rest SPECT 
MPS.  Nearly half (48.8%) of the subjects included in the present investigation were referred 
through the ED. The second referral source is primary care and cardiology physicians.  These 
patients typically have both the rest and stress portions of the study done on the same day. The 
remaining 51.2% of the subjects in this study were referred in this manner.   Given this, various 
SPECT MPS protocols were utilized depending on patient characteristics and nuclear isotope 
availability.  During the data collection period there was a worldwide shortage of one of the 
commonly used nuclear isotopes, technetium 99 (aka tetrofosmin).  As a substitute, thallium-201 
(TL-201) was used.  It has been shown that TL-201 and tetrofosmin are similar in detecting 
CAD.
100
 All SPECT MPS were done with ECG gating (16 time frames in the heart cycle) to 
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allow for determination of global and segmental left ventricular function as well as for detection 
of perfusion abnormalities.  Forty percent of the tests were done with technetium and in the 
remainder thallium was used.       
Each result was categorized as the presence and extent of reversibility according to the 
following:  0/normal = no evidence of attenuation or reversibility or fixed defect likely due to 
soft tissue attenuation; 1/equivocal = small size and low grade reversible defect; 2/mildly 
abnormal = small size and moderate grade or moderate size and low grade reversible defect; 
3/moderately abnormal = moderate size and moderate grade reversible defect; 4/severely 
abnormal = moderate size and high grade or large size and high grade reversible defect.   
 
Standard Exercise Test Procedures 
All exercise tests were done on a motorized treadmill (GE Healthcare Series 2000, 
Waukesha, WI) using the Bruce Protocol.
101
  Exercise testing procedures outlined by the 
American Heart Association were followed for all assessments.
3, 102
  All patients were 
continuously monitored by a 12-lead ECG (GE Marquette 12SL, Waukesha, WI) and 
hemodynamic measurements were made during each stage of the protocol.  Blood pressure was 
measured with an automated sphygmomanometer (SunTech Tango+, Morrisville, NC) with 
auditory confirmation. Patients were encouraged to exercise to their maximum tolerance.  
Maximum heart rate (MHR) was defined as heart rate at peak exercise.  Age-predicted maximum 
heart rate (APMHR) was calculated with the following: APMHR = 220 – age.  Percent-predicted 
maximum heart rate (PPMHR) was calculated with the following: (MHR/APMHR)*100.  
Maximum systolic blood pressure (SBP) and diastolic blood pressure (DBP) were defined as 
SBP and DBP at peak exercise.  The following exercise test termination criteria were used:  
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onset of severe typical angina, arrhythmias (frequent premature ventricular contractions; greater 
than or equal to 3 beats of non sustained ventricular tachycardia; new onset atrial fibrillation, 
atrial flutter or atrial tachycardia with rapid response; second or third degree heart block), 
hypotension, bradycardia or decrease in heart rate with same or greater workload, dyspnea, 
intermittent claudication, central nervous system symptoms, marked hypertension, greater than 2 
mm of horizontal or down sloping ST segment depression or ST elevation ≥ 1 mm, and patient's 
request to stop or inability to keep up with the treadmill.  
Dyspnea and angina were measured using 4 point scales.
102
  For level of exertion, the 6-
20 Borg Rating of Perceived Exertion (RPE) scale was used.
103
    
 
Cardiopulmonary Exercise Test Procedures 
 Ventilatory expired gas was collected for each test using a metabolic cart (Vmax Encore, 
SensorMedics, Yorba Linda, CA). Before each test, the equipment was calibrated in standard 
fashion using reference gases and a 3-liter syringe.  Ventilatory expired gas analysis data 
collection began at rest and continued throughout the duration of the test.  The first minute was 
used to familiarize the subject to the equipment, to normalize ventilatory pattern and to allow for 
collection of baseline data.   
Minute ventilation (VE), oxygen consumption (VO2), and carbon dioxide production 
(VCO2) were acquired breath-by-breath, and averaged over 10-second intervals.  Peak VO2 is 
expressed as the highest 30-second averaged sample obtained during the exercise test in 
mLO2•kg
-1•min-1.  Peak respiratory exchange ratio (RER) is expressed as the highest averaged 
sample obtained during the exercise test.  For the oxygen uptake efficiency slope (OUES), VE, 
averaged over 10 second intervals, was transformed into its logarithmic equivalent.  The OUES 
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was determined via least squares linear regression (VO2 = a log10VE + b; VO2 and VE are 
expressed in L/min) by spreadsheet software (Microsoft Excel, Microsoft Corp., Bellevue, 
WA).
80
 All exercise data were used to calculate the OUES. Change in OUES (OUES50-75) was 
calculated by determining the difference between the value of OUES from the first half of the 
exercise bout (OUES50) and the last 25% of the exercise bout (OUES75).  VE and VCO2 values, 
acquired from the initiation of exercise to peak, were entered into spreadsheet software 
(Microsoft Excel, Microsoft Corp., Bellevue, WA) to calculate the VE/VCO2 slope via least 
squares linear regression (y = mx + b, m=slope).  A change in VE/VCO2 slope (VE/VCO250-75) 
was assessed in the same manner as described for OUES.  The O2 pulse was calculated in 30 
second intervals by dividing VO2 by heart rate at rest and throughout exercise.  Peak O2 pulse 
was the highest 30-second averaged value during the exercise bout.  Oxygen pulse flattening 
duration, initially described by Belardinelli et al
50
, was calculated as total exercise time minus 
time at which peak O2 pulse occurred.  Change in O2 pulse was calculated as the difference 
between the highest O2 pulse during exercise and the resting value.   
 
Statistical Analysis 
Statistical analysis was performed using SPSS 17.0 (SPSS Inc, Chicago, IL).  Unpaired 
student’s t-test was used to compare continuous variables of interest between subjects.    One 
way ANOVA was used to compare clinical, hemodynamic and metabolic interval data among 
groups of subjects stratified according to the three levels of MPS result (negative, equivocal, and 
mild – severe).  The Kruskal-Wallis test compared differences in ordinal data (i.e. RPE, dyspnea, 
angina scales), while chi-square analysis assessed differences in nominal data (i.e sex, race) 
amongst the three groups.  Receiver operator characteristic (ROC) curve analysis was used to 
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assess the predictive ability of key ECG stress test and CPX variables.  When an area under the 
curve (AUC) was found to be significant and an optimal threshold value was identified, a two-
by-two contingency table was constructed to determine the relative risk ratio and 95% 
confidence interval of that given threshold. Due to the known impact of beta-blocking agents on 
the heart rate response
104
 during exercise, a subgroup analysis was performed on the diagnostic 
utility of key variables in subjects who were not prescribed a beta-blocking agent.  Lastly, the 
ability of standard exercise test and ventilatory expired gas variables to identify subjects with a 
reversible myocardial perfusion defect was separately performed in males and females.  All 
statistical tests with a p-value <0.05 were considered significant.   All means are expressed ± 
standard deviation. 
 
Results 
Three hundred and three subjects (157 males, 146 women) successfully completed all 
assessment procedures.   Mean age and BMI were 49.9 ±11.6 years and 30.4 ±6.5 kg/m
2
, 
respectively.  The majority of subjects (86.1%) had no history of heart disease.  Of these, 8.3% 
had undergone cardiac catheterization without intervention.  Ten percent of subjects had a 
history of CAD: 8.9% percent had a previous PCI, and 1.1% had a myocardial infarction (MI) 
without intervention. Electrical abnormalities and mild valvular disorders were present in 3.9% 
of the subjects.  The majority (73.6%) were taking prescribed medications on the day of the test.  
Of these, slightly more than half (55.0%) were taking an anti-hypertensive, 31.4% were taking a 
lipid-lowering agent, 28.1% were taking aspirin and 11.2% were taking a medication for diabetic 
management.  More than half (57.4%) reported no regular physical activity.  Another 27.7% 
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reported exercising less than 3 days per week and only 14.8% reported participation in exercise 
on 4 days or more per week.   The mean number of cardiovascular risk factors was 3.0 ±1.5.   
Resting heart rate was not different between males and females (72.2 ±15.0 vs. 74.8 
±14.1, respectively; p = 0.11) however, resting blood pressure was significantly higher in males 
vs. females (137.3 ±21.4/84.1 ±13.1 vs 130.8 ±18.6/80.7 ±9.4 mmHg, respectively; p <0.05).   
Resting O2 pulse was higher in males vs. females (15.7 ±4.7 vs. 14.6 ±3.2 mL/beat, p<0.05).     
Two hundred and two subjects (66.7%) had a normal myocardial perfusion study, 69 
subjects (22.8%) had an equivocal study and 32 (10.5%) had a mildly, moderately or severely 
abnormal stress MPS.  Of those with an abnormal result, the percent of myocardium involved 
ranged from 1-14%, with a mean of 4.39 ±3.31%.  The majority of the defects were small in size 
(72.5%) and low in grade (84.2%).  Wall motion abnormalities were present in 7.6% of those 
with an abnormal stress MPS.  The frequency of negative, equivocal and positive MPS was 
different among men and women (93, 42, 22 vs. 109, 27, 10, respectively; p <0 .01).   
There was no difference in age between each of the MPS groups (Table 1).  Males 
formed a higher percentage of patients in the mild – severe group and the equivocal MPS group 
than in the negative group.  Patients with a mild – severe defect had a significantly higher BMI 
than the negative group and more risk factors than either the equivocal or negative groups.  
Patients in the mild – severe group were more likely to have typical chest pain or shortness of 
breath than those in the equivocal or negative group.  Treadmill time was significantly less in the 
mild – severe group compared to the negative perfusion group and was significantly less in the 
equivocal group than the mild–severe group. Finally, OUES50-75 was significantly different in 
the mild–severe perfusion defect group than in the negative group.    
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Of the 303 subjects, 285 (94.1%) completed the protocol with no ST segment changes 
indicative of ischemia.  Nine subjects (3%) had at least 1 mm, eight subjects (2.6%) had at least 
2 mm, and two subjects (0.7%) had at least 3 mm of ST segment depression in at least one lead.  
Standard ECG stress testing was unable to identify subjects with a positive MPS (including 
equivocal tests or when only mild–severe perfusion defects were considered). (Table 2)  
The duration of O2 pulse flattening was not able to identify subjects with a positive MPS.  
This finding was consistent regardless of degree of perfusion defect, beta-blockade status, or 
gender.  OUES50-75 produced a statistically significant diagnostic model which remained so 
regardless of beta blockade status.  It was more strongly predictive of a positive MPS among 
those with mild–severe ischemia.  A change in VE/VCO2 slope (VE/VCO250-75) was found not 
to be diagnostically significant for MPS result. (Table 2) 
When considering males alone, the ability of OUES50-75 to identify a positive MPS 
increased, especially in those with mild–severe perfusion defects (table 2).  Additionally, a 
change in O2 pulse from rest to peak was predictive of mild–severe ischemia in males only.  
None of the diagnostic models were statistically significant in the female subgroup (Table 2).     
In the male group, optimal diagnostic thresholds for O2 pulsepeak-rest and OUES 50-75 
were 10 ml/beat and 0, respectively.  Male subjects with an OUES < 0 (i.e any amount of decline 
in slope) were 2.0 times more likely (95% CI [1.4, 3.0], p< 0.001) to have any degree of 
perfusion defect and 5.4 times more likely (95% CI [2.1, 13.8], p< 0.001) to have a mild–severe 
perfusion defect.  Figure 2 illustrates two cases from the present investigation; one in which the 
OUES remains generally linear while the other depicts a substantial decline at the terminal 
portion of exercise.  The former had a negative MPS while the latter had a moderate perfusion 
defect. Male subjects with an O2 pulsepeak-rest < 10 were 3.6 times more likely (95% CI [1.7, 7.8], 
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p<0.05) to have a perfusion defect that was mild–severe.  Relative risk ratios for the OUES 50-
75 are illustrated in Figure 1.       
 
Discussion 
To our knowledge, the present study is currently the largest prospective analysis on the 
use of ventilatory expired gas in conjunction with traditional exercise testing procedures to aid in 
the non-invasive diagnosis of CAD.  Importantly, this is the first study to include a majority of 
patients without a prior diagnosis of CAD, providing a better reflection of the type of patient 
being referred for this type of assessment in the current clinical environment.  Moreover, a 
significantly greater percentage of females were included compared to similar previous 
investigations.
95
     
The OUES finding is novel.  Baba et al
105
 first described the OUES in 1996 in a study 
assessing cardiovascular function in a group of children with congenital heart disease.  OUES is 
a single point item that reflects both cardiovascular and pulmonary function.   Previous research 
has shown the OUES to be strongly linear throughout a progressive exercise test
106-108
.  It is the 
strong linearity of the OUES that makes real-time deviations particularly attractive as a potential 
diagnostic tool.  Under the condition of left ventricular dysfunction secondary to myocardial 
ischemia, an abnormal decline in OUES may be posited and the present investigation 
demonstrates that such a response at the terminal portion of exercise is in fact reflective of an 
abnormal MPS in male subjects.     
Previous investigations have focused primarily on the ability of OUES to act as a 
surrogate for peak VO2, one that is independent of effort and stable across the exercise duration.  
It has been repeatedly shown to be highly correlated with peak VO2 and the VE/VCO2 slope in 
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patients with heart failure and those with confirmed CAD.
109-111
  Although it cannot predict peak 
VO2
111
 it has been shown to classify subjects with intermediate peak VO2 values into clinically 
important categories and is sensitive to aerobic exercise training.
81
  It has also been shown that 
OUES is significantly higher in subjects following PCI with or without history of myocardial 
infarction compared to subjects undergoing coronary artery bypass surgery with or without 
myocardial infarction.  This suggests that OUES is sensitive to disease severity.  The use of real-
time change in the OUES to indicate the likelihood of an abnormal MPS has not previously been 
reported.  However, one previous investigation by Arena et al.
106
 found a real-time decline in the 
OUES was correlated with increasing aortic stiffness in apparently healthy subjects.  This 
previous investigation supports the hypothesis that real-time change in the OUES is reflective of 
cardiovascular health and function.   
Analysis of the real-time trajectory of O2 pulse behavior (i.e. flattening time) in this study 
was not predictive of an abnormal MPS.   However in males O2 pulsepeak-rest emerged as a 
predictor of ischemia.  This result both validates and refutes previous findings.  It is important to 
note that in most of the studies to-date, in contrast to our study, the majority of the subjects were 
male.  For example, in the Belardinelli and Munhoz studies, men represented 86% and 71% of 
the participants, respectively.
50, 52
  In contrast, in the present study nearly 50% of the subjects 
were female.  Interestingly, we found that a change in O2 pulse (O2 pulsepeak –O2 pulserest) was 
predictive of a mild–severe perfusion defects only in males.  This result seems to validate the 
findings of Munhoz et al. who showed that peak O2 pulse was significantly different in those 
with mild vs. moderate or severe ischemia.
52
  However, O2 flattening duration, as Belardinelli 
assessed it
50
, was not predictive of abnormal MPS.   
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There are a number of potential explanations for the lack of predictive ability of O2 pulse 
in the whole cohort.  First, previous studies included only patients with an established diagnosis 
of CAD, who likely had lower resting ejection fraction and were older, likely leading to worse 
baseline and exercise myocardial function.  Moreover, only a small percentage (approximately 
10%) of the subjects in this study had definite evidence of ischemia which was largely mild.  In 
contrast, in the Belardinelli cohort,
50
 most (70%) had evidence of moderate-severe ischemia.  
Ultimately, in the relatively younger and healthier cohort included in the present analysis, there 
may exist a greater ability to adapt to small declines in LV function.  In other words, O2 pulse 
may lack the necessary resolution to detect small changes. Conversely, the OUES response to 
progressive exercise is tightly linear under normal physiologic conditions as has been shown in a 
group of patients with stable CAD.
112
  Thus, even the onset of low level LV dysfunction at the 
terminal portion of exercise may be reflected by a decline in the OUES. 
As was previously noted, neither VE/VCO2 slope using 100% of the exercise data, nor 
the change in slope was diagnostic for a positive MPS of any level.  VE/VCO2 slope has been 
shown to be of particular value in the heart failure patient population where an abnormally 
elevated slope (i.e. ≥34) has been shown to be highly prognostic for future morbidity and 
mortality from cardiovascular events.  In the current cohort, the mean VE/VCO2 slope was 22.2 
±3.3, well within the range of what would be considered a normal response.  Given this low 
variability amongst the response, it may be there was low diagnostic resolution to detect small 
changes.  Moreover, the production of CO2 is highly variable given individual metabolic 
attributes and fitness level and while the VE-VCO2 relationship is generally linear, there is more 
variability compared to the OUES.  This increased variability in the linear presentation of the 
VE/VCO2 slope may have also contributed to the lack of diagnostic ability of this variable.    
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The findings of the present study relating to diagnostic disparity according to gender may 
be at least partially explained by baseline differences.  The males in this study had significantly 
lower ejection fractions, lower maximal HR, and higher peak systolic blood pressure.  This may 
reflect a greater pre-test likelihood for having a positive test since these variables have been 
associated with worse overall function.  However, a more compelling explanation may be related 
to the differing presentation of ischemic heart disease in men and women.  First, women with 
complaints of chest pain are much less likely to have anatomically significant coronary artery 
stenosis (defined as > 50% lesion) than men with similar complaints.
113
  Despite this, women 
have greater rates of myocardial ischemia, worse prognosis and consume greater health care 
dollars in an attempt to diagnose and treat ischemic heart disease.
114
  In a recent review, Shaw et 
al.
115
 summarized previous research indicating the various etiologies of ischemic heart disease in 
women to include abnormal coronary activity, microvascular dysfunction, subendocardial 
ischemia and plaque erosion/distal microembolization.  This difference in presentation may 
impact the accuracy of commonly used tests.
116
  For example, SPECT MPS performed with 
thallium results in lower specificity and sensitivity to detect myocardial ischemia in women.  
Echocardiography and the use of ECG gating during SPECT MPS, which allow the 
quantification of ejection fraction and the visualization of wall motion abnormalities, result in 
greater accuracy.
117
  In addition, the adoption of technetium as the nuclear isotope of choice 
appears to mitigate this problem.  Although the present investigation did not elucidate a 
predictive model for the detection of a positive MPS it is possible that the differences relate to 
the gold standard used and not the CPX itself. Emerging techniques may provide a solution to 
this gender-related difference in diagnostic accuracy and supports future analyses into the value 
of exercise testing with ventilatory expired gas analysis in female cohorts.  Cardiac magnetic 
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resonance imaging (cMRI)  may be better at detecting the underlying pathology of ischemic 
heart disease in females by determining blood flow through coronary arteries and evaluating 
myocardial metabolism.
118, 119
  One small study found subendocardial hypoperfusion,  largely 
undetectable by today’s clinical  standards, in a group of mostly female patients with angina, 
exercise-induced ST segment changes but non-obstructive CAD (i.e Syndrome X).
120
  Therefore 
assessment of the diagnostic potential of an abnormal OUES change, in females with suspected 
myocardial ischemia, while using cMRI as the gold standard seems to be a viable direction for 
future investigations.   
A limitation of this study is the lack of cardiac catheterization data to confirm the MPS 
results.  The majority of patients had normal or relatively mild perfusion defects and a low risk 
profile, so angiography would not be clinically indicated.  However, previous research has 
demonstrated a positive MPS is a significant predictor of adverse events regardless of 
catheterization findings.
121
  Moreover, several studies have shown the prognostic significance of 
endothelial dysfunction in patients, especially women, with “normal” coronary arteries.122  It 
should be noted that the gold standard of coronary angiography has important limitations.  For 
example, in patients with chest pain but negative catheterization, intravascular ultrasound, which 
assesses anatomy beyond lumen diameter, consistently shows morphological changes throughout 
the arterial tree.
123, 124
  The current study also has a component of work-up bias as patients with a 
high pre-test likelihood of CAD typically proceed directly to cardiac catheterization as the first 
line diagnostic assessment.  This limits the ability of this study to describe the full range of CPX 
responses from none to mild to severe disease. Given that previous investigations can be relied 
on for these responses, the present one may better reflect the type of patient being referred for 
exercise testing, providing a better representation of current clinical practice. 
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Despite these limitations, this study provides evidence of the potential clinical 
applicability of CPX in the diagnosis of CAD.  Although the results raise additional questions, in 
particular related to the use of CPX with MPS as a gold standard in women, a few initial 
conclusions can be made.  First, the use of CPX has a potential role in the diagnosis of CAD as 
has been demonstrated by this and previous studies over the past 30 years.  Second, CPX can be 
used in an “all-comers” clinical population with mixed risk (low to high) for having CAD.  
Additionally, the assessment of O2 pulse appears to have some clinical value in this patient 
population and for the first time a measure of ventilatory efficiency has proven to be reflective of 
abnormal myocardial perfusion.   
A natural follow-up question is when and where CPX should be incorporated into the 
diagnostic work-up of patients with suspected CAD.  The addition of ventilatory expired gas 
may not be warranted when stress MPS is performed in conjunction with standard exercise stress 
testing procedures.  However, in centers with fewer resources that continue to solely rely on the 
standard exercise stress test (i.e. ECG, hemodynamics and symptomatology) to determine the 
likelihood of LV dysfunction secondary to myocardial ischemia, the addition of ventilatory 
expired gas analysis may be warranted to improve diagnostic accuracy. Additionally, the 
evolution of ventilatory expired gas technology has substantially reduced the space requirements 
and cost of this equipment, factors which certainly increase the likelihood of acceptance by 
clinicians operating exercise stress testing laboratories.  Future research is needed to clarify this 
issue and determine if a paradigm shift in the diagnostic assessment of patients with suspected 
CAD is needed.   
In conclusion, as a stand-alone procedure, the traditional exercise stress test is limited in 
its ability to accurately diagnose clinically significant CAD.  These limitations have led to the 
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addition of MPS and other imaging strategies to more accurately identify those with myocardial 
ischemia.  While this practice will certainly continue, smaller clinical centers unable to perform 
nuclear imaging may still have to rely of the exercise stress test as a first-line assessment of 
patients with suspected CAD.  The results of the present study indicate the addition of CPX to 
the standard exercise stress test may significantly improve the ability to accurately identify males 
with abnormal myocardial perfusion.  The diagnostic utility of exercise stress testing with CPX 
in females is undetermined at this time.  Utilization of a gold standard diagnostic test with 
greater accuracy in females may be needed to address this unresolved issue.  Past investigations 
in conjunction with the findings of the present study certainly warrants the continuation of 
research examining the potential diagnostic value of CPX in patients with suspected CAD. 
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Table 1:  Baseline and Exercise Differences By MPS Result 
 
Negative 
(n=202) 
Equivocal 
(n=69) 
Mild – Severe 
(n=32) 
Age (years) 49.5 ±10.8 50.23 ±13.1 51.8 ±12.6 
Gender (% male) 46 61# 69* 
BMI 29.5 ±6.2 31.5 ±6.2 33.7 ±7.8* 
Number of Risk Factors 2.9 ±1.5  3.2 ±1.4^ 3.7 ±1.5* 
Cardiac History (% with 
CAD) 6.9 14.5# 21.9* 
Chief Complaint (%)    
 Atypical Chest Pain 67.2 66.1 51.6* 
 Typical Chest Pain 14.0 13.2 25.8* 
 SOB 8.5 4.4^ 13.0* 
Rest Hemodynamic Data 
HR (bpm) 73.6 ±14.4 71.6 ±14.5 76.6 ±14.5 
SBP (mmHg) 133.3 ±18.9 135.1 ±17.2 137.7±32.0 
DBP (mmHg) 82.6 ±10.7 82.1 ±9.9 82.5 ±11.6 
Exercise Hemodynamic and Ventilatory Data 
Max HR (bpm) 152.0 ±18.9 145.5 ±20.2# 146.4 ±14.9 
PPMHR (%) 89.2 ±9.8 85.9 ±11.2 87.4 ±9.7 
Max SBP (mmHg) 185.2 ±25.8 182.8 ±20.9 193.3 ±28.5 
Max DBP (mmHg) 88.1 ±14.8 87.0 ±17.2 90.0 ±17.0 
RPP (max SBP*max HR) 
28 148.2 
±5103.0 26 671.9 ±5001.2 28 369.1 ±5385.5 
TM Time (sec) 435.8 ±167.0 442.7 ±159.6^ 357.6 ±146.2* 
RPE 14.6 ±2.7 14.7 ±2.2 14.4 ±3.9 
DOE 1.7 ±1.3 1.8 ±1.3 2.0 ±1.5 
Chest Pain 0.3 ±0.8 0.5 ±1.0 0.41 ±1.0 
Peak RER 1.10 ±0.1 1.09 ±0.2 1.12 ±0.2 
Peak VO2 (mLO2•kg
-1•min-1) 23.2 ±7.0 22.32 ±5.7 20.7 ±7.0 
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O2 Pulse Flat Duration (sec) 70.73 ±79.0 79.3 ±97.4 61.34 ±73.0 
O2 Pulsepeak-rest 9.7 ±3.3 10.5 ±3.3 9.7 ±3.9 
VE/VCO2 slope 22.0 ±3.0 22.3 ±3.7 23.2 ±4.5 
VE/VCO2 slope50-75 5.2 ±6.3 5.2 ±6.7 4.4 ±6.9 
OUES100 2.5 ±0.76 2.6 ±0.66 2.6 ±1.0 
OUES50-75 0.27 ±1.1 0.09 ±1.1 -0.4 ±1.3* 
# p<.05 neg vs equivocal 
* p<.05 neg vs mild/severe 
^ p <.05 equiv vs mild/severe 
 
Abbreviations: BMI: body mass index; CAD: coronary artery disease; SOB: shortness of breath; RHR: rest heart rate; SBP: 
systolic blood pressure; DBP: diastolic blood pressure; PPMHR: percent predicted maximal heart rate; RPP: rate pressure 
product; TM: treadmill; RPE: rating of perceived exertion; DOE: dyspnea on exertion; RER: respiratory exchange ratio; 
OUES: oxygen uptake efficiency slope. 
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Table 2: Comparison of Predictive Models via ROC Analysis 
 
Area Under Curve (95% CI) 
Full Cohort 
(n=303) 
No Beta-Blockade 
(n=238) 
Males Only 
(n=157) 
Females Only 
(n=146) 
All 
Mild-
Severe 
All  
Mild-
Severe 
(n=22) 
All 
Mild-
Severe 
(n=22) 
All 
Mild-
Severe 
(n=10) 
ST Segment 
Depression 
.49 
(.42,.56) 
.48 
(.37,.59) 
.51 
(.43,.59) 
.49  
(.37,.62) 
.48 
(.38,.57) 
.48  
(.35,.62) 
.48  
(.38,.59) 
.52  
(.33,.72) 
O2Pulse Flat. 
Duration 
.50 
(.44,.57) 
.53 
(.44,.63) 
.51 
(.43,.59) 
.54 
(.43,.64) 
.52 
(.43,.61) 
 .52  
(.40,.64) 
.52  
(.41,.62) 
.45  
(.29,.61) 
O2PulsePeak-
Rest 
.45 
(.38,.52) 
.54 
(.43,.65) 
.48  
(.37,.53) 
.50 
(.36,.64) 
.51 
(.42,.60) 
.66* 
(.52,.80) 
.47  
(.37,.58) 
.46  
(.25,.68) 
OUES 
50-75 
.59* 
(.52,.65) 
.67* 
(.57,.77) 
.59* 
(.51,.67) 
.65* 
(.52,.77) 
.67* 
(.59,.76) 
.76* 
(.67,.85) 
.51  
(.40,.62) 
.49  
(.26,.72) 
VE/VCO2 
50-75 
.50 
(.43,.57) 
.51 
(.40,.62) 
.52 
(.44,.60) 
.55 
(.42,.69) 
.48  
(.39,.57) 
.50 
(.36,.64) 
.47  
(.36,.58) 
.44  
(.25,.62) 
*p<  0.05 
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* p < .05 
Figure 1: Relative Risk for OUES 50-75 Threshold of Zero 
 
 
 
 
(A) 
 
Increase (0.5) in OUES50-75 and no perfusion defect 
 
 
 
(B) 
 
Decrease  (-3) in OUES and moderate perfusion defect 
Figure 2: Examples of Change in OUES 
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Chapter 3: Overestimation of Aerobic Capacity with the Bruce Treadmill Protocol in 
Patients being Assessed for Suspected Myocardial Ischemia 
 
ABSTRACT 
 
Introduction: Peak oxygen consumption (VO2) is highly prognostic for morbidity and mortality 
from a wide range of illnesses, including coronary artery disease (CAD). The practice of 
estimating aerobic capacity during traditional exercise stress testing is common as it has been 
shown that total treadmill time or speed and grade on the Bruce protocol predicts peak VO2.  
However, the potential to overestimate peak VO2 exists and may have significant clinical 
implications regarding the interpretation of exercise test data.  The purpose of the present study 
is to investigate this issue in a large cohort of patients with suspected CAD undergoing exercise 
stress testing and nuclear myocardial perfusion imaging. 
Methods: Three hundred and three subjects with symptoms suggestive of myocardial ischemia 
underwent a single photon emission computed tomography myocardial perfusion study and an 
exercise test with simultaneous analysis of ventilatory expired gas.  Estimated VO2 from the 
Bruce treadmill protocol was compared to measured VO2.  The Duke Treadmill Score (DTS) 
was calculated with treadmill time (DTStime) and also with measured VO2 (DTSmeasured), 
expressed as metabolic equivalents (METs), and converted to time using an established equation.   
Results:  Peak measured METs was significantly lower than peak estimated METs in the whole 
cohort (6.5 ±1.9 vs. 8.8 ±2.8, p <0.001) as well as in female (5.7 ±1.4 and 7.8 ±2.1, p<0.001) and 
male (7.3 ±2.0 and 9.7 ±3.1, p<0.001) subgroups. Calculation of the DTS with measured METs 
resulted in a significantly lower score compared to its calculation with treadmill time (2.7 ±3.5 
vs. 5.8 ±4.6, p < 0.001).  The DTSmeasured and DTStime for women (2.1 ±3.5 and 4.7 ±4.2, 
respectively, p < 0.001) were both significantly lower than for men (3.3 ±3.5 and 6.9 ±4.6, 
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respectively, p < 0.001).  Receiver operating characteristic curve analysis revealed that 
DTSmeasured produces a statistically significant model for diagnosing a reversible perfusion defect 
in both men and women (p<0.05), while DTStime was only diagnostic in men (p<0.05).  
Conclusions:   This study demonstrates that estimates of aerobic capacity are significantly 
higher than measured values and this difference may result in a significant underestimation of 
risk from all cause or cardiovascular mortality.  
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Introduction 
The traditional exercise electrocardiogram (ECG) test, or stress test, has been a first line 
clinical standard for the non-invasive detection of coronary artery disease (CAD) for several 
decades.  The Duke Treadmill Score (DTS), developed in 1987 by Mark et al.,
125
 incorporating 
Bruce Protocol treadmill time, ST segment changes and angina into a single score,  has been 
shown to be prognostic of future events and diagnostic of significant and/or severe coronary 
stenosis.
126
  Even before the publication of the original DTS paper, the Bruce Protocol was the 
most frequently used protocol in clinical practice for the purpose of assessing individuals with 
suspected CAD.
127
  Currently, there is evidence suggesting it is even more widely used, which is 
likely a consequence of the wide acceptance of the DTS.
128
   
Aerobic capacity, as measured by peak oxygen consumption (VO2) and commonly 
expressed in units of metabolic equivalents (METs) where 1 MET = 3.5 mLO2•kg
-1•min-1, is 
highly prognostic for morbidity and mortality from a wide range of illnesses, including 
cardiovascular disease.  In fact, a recent meta-analysis incorporating data from over 100,000 
subjects found that for every 1 MET increase in aerobic capacity there was a 13% and 15% 
decrease in risk of all cause mortality and cardiovascular events, respectively.
129
  
Cardiopulmonary exercise testing (CPX), a technology not frequently utilized in stress testing 
laboratories, directly measures VO2 thus providing accurate quantification of aerobic capacity.  
The total treadmill time on the Bruce protocol has been shown to predict peak VO2,
101
 however; 
the large degree of error associated with its estimation  in this way has been demonstrated by 
numerous investigators.
130, 131
  This is particularly true when employing a treadmill protocol with 
large per-stage increases in exercise intensity, such as the Bruce, in individuals who are 
deconditioned or have cardiovascular and/or pulmonary disease.
128, 132
   Despite this significant 
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limitation, estimating rather than directly measuring VO2 remains the standard.  The degree of 
error in estimated aerobic capacity in patients undergoing exercise stress testing is not well 
characterized, nor is it known if this is clinically significant with respect to data interpretation.  
Therefore, the present investigation attempts to answer the following questions: 1) is measured 
VO2 different from estimated VO2 in a population of men and women undergoing evaluation for 
possible CAD, and 2) will the difference between measured and estimated VO2 change 
diagnostic scores or prognostic risk estimates?   
 
Methods 
The current investigation prospectively assessed 303 patients who presented to the Non-
Invasive Stress Laboratory of Virginia Commonwealth University Medical Center from May 
2009 to February 2010. Common indications included chest pain (65.3%), dyspnea (8%), history 
of CAD (5%) syncope (1.3%), palpitations (3%) and/or abnormal ECG (2.4%).  Exclusion 
criteria were myocardial infarction or percutaneous coronary intervention (PCI) within three 
months of testing, previous diagnosis of congestive heart failure, known left ventricular ejection 
fraction <35%,  evidence of moderate lung disease by pulmonary function test, moderate or 
severe aortic or mitral valve stenosis, unstable angina or uncontrolled hypertension, previous 
pacemaker implant or coronary artery bypass grafting, orthopedic/neurologic conditions that 
limited exercise performance, and/or inability to collect interpretable ECG and nuclear imaging 
data.  Cardiac risk factors were recorded and included hypertension, lipid profile, tobacco use, 
family history of early coronary disease, physical activity and diabetes.   Physical activity 
frequency, duration and intensity were measured by patient self-report.  Exercise tests were 
performed in the fasting state and patients were instructed to avoid all caffeine-containing food 
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or drink in the 4 hours prior to the test.  Patients were instructed to follow the recommendation of 
their physician on taking prescribed medications.   
The protocol was approved by the Institutional Review Board at Virginia Commonwealth 
University.  All subjects signed an informed consent prior to inclusion in the study. 
 
Nuclear Myocardial Perfusion Imaging Procedures 
All subjects had the stress portion of a single photon emission computed tomography 
(SPECT) myocardial perfusion study (MPS) the same day as the standard exercise test with 
ventilatory expired gas analysis.  However, based on referral source and/or patient 
characteristics, some subjects underwent the rest portion of the MPS on a different day.  Briefly, 
two main referral sources exist for this clinic.  The first is the Emergency Department (ED) from 
which patients are referred for follow up stress MPS after undergoing an evaluation for possible 
myocardial ischemia or infarction.  At the time of the ED visit patients undergo rest SPECT 
MPS.  Nearly half (48.8%) of the subjects included in the present investigation were referred 
through the ED. The second referral source is primary care and cardiology physicians.  These 
patients typically have both the rest and stress portions of the study done on the same day. The 
remaining 51.2% of the subjects in this study were referred in this manner.  
Given this, various SPECT MPS protocols are utilized depending on patient 
characteristics and nuclear isotope availability.  During the data collection period there was a 
worldwide shortage of one of the commonly used nuclear isotopes, technetium 99 (aka 
tetrofosmin).  As a substitute, thallium-201 (TL-201) was used.  It has been shown that TL-201 
and tetrofosmin are similar in detecting CAD.
100
 All SPECT MPS were done with ECG gating 
(16 time frames in the heart cycle) to allow for determination of global and segmental left 
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ventricular function as well as for detection of perfusion abnormalities.  Forty percent of the tests 
were done with tetrofosmin and in the remainder TL-201 was used.       
Each result was categorized as the presence and extent of reversibility according to the 
following:  0/normal = no evidence of attenuation or reversibility or fixed defect likely due to 
soft tissue attenuation; 1/equivocal = small size and low grade reversible defect; 2/mildly 
abnormal = small size and moderate grade or moderate size and low grade reversible defect; 
3/moderately abnormal = moderate size and moderate grade reversible defect; 4/severely 
abnormal = moderate size and high grade or large size and high grade reversible defect.   
 
Standard Exercise Test Procedures 
All exercise tests were done on a motorized treadmill (GE Healthcare Series 2000, 
Waukesha, WI) using the Bruce Protocol.
101
  Subjects were instructed by the clinician 
conducting the test to rest both hands on the front handrail for support throughout the test to 
minimize the risk of loss of balance or falling.  Exercise testing procedures outlined by the 
American Heart Association were followed for all assessments.
3, 102
  Patients were continuously 
monitored by a 12-lead ECG (GE Marquette 12SL, Waukesha, WI) and hemodynamic 
measurements were made during each stage of the protocol.  Blood pressure was measured with 
an automated sphygmomanometer (SunTech Tango+, Morrisville, NC) with auditory 
confirmation.  Patients were encouraged to exercise to their maximum tolerance.  Maximum 
heart rate (MHR) was defined as heart rate at peak exercise.  Age-predicted maximum heart rate 
(APMHR) was calculated with the following: APMHR = 220 – age.  Percent-predicted 
maximum heart rate (PPMHR) was calculated with the following: (MHR/APMHR)*100.  
Maximum systolic blood pressure (SBP) and diastolic blood pressure (DBP) were defined as 
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SBP and DBP at peak exercise.  The following exercise test termination criteria were used:  
onset of typical angina, arrhythmias (premature ventricular contractions; greater than or equal to 
3 beat run of ventricular tachycardia; new onset atrial fibrillation, atrial flutter or tachycardia 
with rapid response; second or third degree heart block), hypotension, bradycardia or decrease in 
heart rate with same or greater workload, dyspnea, intermittent claudication, CNS symptoms, 
marked hypertension, greater than 3 mm of horizontal or down sloping ST segment depression or 
ST elevation ≥ 1 mm, and patient's request to stop.  
 
Cardiopulmonary Exercise Test Procedures 
 Ventilatory expired gas was collected for each test using a metabolic cart (Vmax Encore, 
SensorMedics, Yorba Linda, CA). Before each test, the equipment was calibrated in standard 
fashion using reference gases and a 3-liter syringe.  Ventilatory expired gas analysis data 
collection began at rest and continued throughout the duration of the test.  The first minute was 
used to familiarize the subject to the equipment, to normalize ventilatory pattern and to allow for 
collection of baseline data.   
 
Data Analysis 
Oxygen consumption (VO2), was acquired breath-by-breath, and averaged over 30-
second intervals.  Peak VO2 is expressed as the highest 30-second averaged sample obtained 
during the exercise test in mLO2•kg
-1•min-1.  Metabolic equivalents (METs) were calculated by 
dividing peak VO2 (mLO2•kg
-1•min-1) by 3.5.  Predicted VO2 was calculated using equations 
proposed by Wasserman.
133
  Percent-predicted peak VO2 was calculated by dividing measured 
peak VO2 by predicted VO2 and multiplying by 100.  Estimated METs were automatically 
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derived by the exercise testing software (GE Cardiac Assessment System for Exercise Testing 
[CASE], Waukesha, WI) and were based on the speed and grade associated with the last stage 
completed on the Bruce Protocol using an established regression equation for walking: [METs = 
(3.5 + 2.68 (speed) + 0.48 (speed) (%grade)/3.5].
134
  Subjects completing ≥2 minutes of a given 
stage of the Bruce protocol were awarded the full estimated METs value.  For subjects 
completing <2 minutes of a given stage, the estimated METs value was determined through 
linear interpolation.  For a separate analysis, subjects completing >9 minutes (i.e. beginning, 
completing or surpassing stage 4) of the Bruce protocol, peak METs were manually calculated 
by this study’s investigators using an established regression equation for jogging/running: 
[METs = (3.5 + 5.36 (speed) + 0.24 (speed) (%grade)/3.5].
134
  For subjects completing <2 
minutes of stage 4 of 5, the estimated METs value was manually determined through linear 
interpolation.  The discrepancy in aerobic capacity, expressed as VO2 or METs, was calculated 
as the difference in peak estimated and peak measured values.  Finally, linear regression using 
maximum estimated METs was used to predict maximum predicted METs.   
The Duke Treadmill Score (DTS) was calculated in two ways.  First, it was calculated 
with treadmill time (TM) according to the following: DTS = TM time – (5 * ST segment 
deviation) – (4 * angina index).  It was also calculated with measured VO2, expressed as METs. 
The following conversion was then used to transform measured METs to treadmill time:  TM 
time = (METs/2.2)+1.3.
16
  In both cases, ST segment deviation was measured in millimeters (by 
an experienced cardiologist) and angina index was scored according to the following: 1= no 
chest pain, 2 = non-limiting chest pain, 3 = exercise-limiting chest pain.  Risk estimates were 
determined by DTS score according to the following: low risk = ≥ +5, moderate risk = -10 – 4, 
and high risk = ≤ -11.125   
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Statistical Analysis 
Statistical analysis was performed using SPSS 17.0 (SPSS, Chicago, IL).  Unpaired t-
testing compared differences in key baseline and exercise test variables according to sex.  Paired 
student’s t-test was used to compare measured and estimated aerobic capacity and DTS in the 
whole cohort.  A mixed model two-way analysis of variance (ANOVA) assessed differences 
between measured and estimated expressions of aerobic capacity and DTS (within subject 
factors) according to sex (between subject factors).  Four separate two-way ANOVA tests were 
performed to assess the discrepancy between peak estimated and measured METs in both males 
and females according to:  1) age, 2) physical activity status, 3) MPS result, and 4) total treadmill 
time.  Both main and interaction effects were assessed.  Paired student’s t-test was again used to 
compare the discrepancy between peak estimated and measured METs using the walking vs. 
jogging/running equation in the subgroup of subjects who completed >9 minutes of the Bruce 
treadmill protocol.  The Pearson’s test was used to determine correlation between age and the 
discrepancy between peak estimated and measured METs.  Receiver operating characteristic 
(ROC) analysis was used to test the ability of the DTS, calculated with TM time or measured 
METs, to diagnose a positive MPS.   All statistical tests with a p-value <0.05 were considered 
significant.   All means are expressed ± standard deviation. 
 
Results 
Three hundred and three subjects, 157 men and 146 women, completed the protocol.  The 
average age was 49.9 ±11.6 and was not different between men and women (50.6 ±12.3 vs. 49.4 
±10.7, p=0.30).  Likewise, mean BMI was 30.4 ±6.5 kg/m
2 
and was similar between the genders 
(30.0 ±6.5 vs. 30.9 ±6.6, p=0.21).  The majority of subjects (86.1%) had no history of heart 
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disease.  Of these, 8.3% had undergone cardiac catheterization without intervention.  Ten percent 
of subjects were known to have CAD: 8.9% percent had a previous PCI, and 1.1% had a 
myocardial infarction (MI) without intervention.  Electrical abnormalities and mild valvular 
disorders were present in 3.9% of the subjects.  The majority (73.6%) were taking prescribed 
medications on the day of the test.  Of these, slightly more than half (55.1%) were taking an anti-
hypertensive, 31.4% were taking a lipid-lowering agent, 28.1% were taking aspirin and 11.2% 
were taking a medication for diabetic management.  More than half (57.4%) reported no regular 
physical activity.  Another 27.7% reported exercising less than 3 days per week and only 14.8 % 
reported participation in exercise on 4 days or more per week.   The mean number of traditional 
cardiovascular risk factors was 3.0 ±1.5.   
Two hundred and two subjects (66.7%) had a normal myocardial perfusion study, 69 
(22.8%) subjects had an equivocal study and 32 (10.5%) had a mildly, moderately or severely 
abnormal MPS.  Of those with an abnormal result, the percent of myocardium involved ranged 
from 1-14%, with a mean of 4.39% ±3.31%.  The majority of the defects were small in size 
(72.5%) and low in grade (84.2%).  Wall motion abnormalities were present in 7.6% of those 
with an abnormal stress MPS.  The frequency of negative, equivocal and positive MPS was 
different among men and women (93, 42, 22 vs. 109, 27, 10, respectively; p < .01).   
Maximal heart rate was significantly lower in females compared to males but no 
difference between percent-predicted maximal heart rate was evident.  Likewise, maximum 
systolic blood pressure was greater in males.  Males exercised significantly longer than females 
(Table 1). Peak measured aerobic capacity was significantly lower than peak estimated aerobic 
capacity in the whole cohort, a trend that persisted in both men and women (Figure 1).    
Moreover, the discrepancy in estimated and measured aerobic capacity was significantly greater 
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for men vs. women.  In the overall group, 74% of the subjects had at least a one MET 
discrepancy between estimated and measured aerobic capacity while 57% had at least a two 
MET discrepancy.  Percent-predicted VO2 derived from estimated aerobic capacity was 
significantly greater than percent-predicted VO2 derived from measured aerobic capacity and the 
difference was greater in women than men (Table 1).  Linear regression using estimated METs to 
predict measured METs was significant (R
2
= 0.58, SEE = 1.24, p<0.001) , however estimated 
METs only accounted for 58% of the variability in actual METs.  Furthermore, the standard error 
of the estimate was greater than 1 MET. 
The discrepancy between peak measured and estimated METs was not different 
according to physical activity patterns, myocardial perfusion imaging result or categorical age 
grouping.  There was, however, a statistically significant, albeit weak, positive correlation 
between MET discrepancy and age expressed continuously (r= 0.12, p < 0.05).  There was a 
significant main effect of treadmill time on METs discrepancy with those exercising > 9 minutes 
having a larger discrepancy than those exercising less than 9 minutes. This significant result was 
consistent in both males and females and no interaction effect between sex-based subgroups.  In 
the aforementioned analysis, peak estimated METs were derived from the walking equation in all 
subjects irrespective of treadmill time (Table 2).   
For those completing > 9 minutes, the treadmill time analysis was repeated with 
estimated peak METs recalculated with the jogging/running equation.  The discrepancy between 
peak measured and the newly estimated METs was still significantly greater in subjects 
completing >9 minutes in the overall cohort (-3.2 ±1.5 vs. -1.7 ±1.5, p<0.001) as well as in males 
(-3.1 ±1.5 vs. -1.6 ±1.6, p<0.001) and females (-3.5 ±1.3 vs.-1.9 ±1.4, p<0.001).  However, the 
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discrepancy was significantly reduced when the jogging/running equation was used to calculate 
peak estimated METs compared to values derived from the walking equation (Figure 2). 
For the whole cohort, calculation of the DTS with measured METs (DTSmeasured) resulted 
in a significantly lower (i.e. worse) score than when it was calculated with time (DTStime), a trend 
that again persisted in gender subgroups. Moreover, both DTS calculations were significantly 
higher in males compared to females (Table 1).  In the whole cohort, the frequency of being 
classified in either a low, moderate or high risk category was significantly different for DTStime 
vs. DTSmeasured (216, 84, 3 vs. 81, 219, 3 respectively, p<0.001).  DTSmeasured resulted in women 
being reclassified into a higher risk category with greater frequency than men.  Specifically, 78 
women were reclassified from low to moderate or moderate to high risk compared to 60 men 
(p<.001).  ROC analysis revealed that both DTSmeasured and DTStime were able to elicit predictive 
models in males (AUC = 0.61 [95% CI: 0.52, 0.70] vs. AUC = 0.60 [95% CI: 0.51, 0.69]; p<0.05 
for both).  Alternately, only DTSmeasured produced a statistically significant model for predicting 
MPS result in females (AUCDTSmeasured = 0.62 [95% CI: 0.52, 0.72], p <0 .05 vs. AUCDTStime = 
0.56 [0.45, 0.66], p=0.32).     
  
Discussion 
Numerous studies have described several variables that should be taken into account in 
order to accurately estimate VO2.  Protocol selection is consistently identified as being one of the 
primary variables.  Appropriate protocol selection is based on age, functional mobility, disease 
status and physical activity patterns.  The Bruce Protocol utilizes stages which introduce a 2-3 
estimated METs increase in exercise intensity every three minutes.  This large per-stage increase 
in work load has been shown to result in overestimation of exercise capacity.
135, 136
  The results 
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of the present study support previous investigations in that aerobic capacity is significantly 
overestimated in both male and female subjects undergoing an exercise stress test that employs 
the Bruce treadmill protocol.  The vast majority of patients in the current study were sedentary 
with 85% reporting less than the recommended daily amount of physical activity (4 days or more 
weekly) although there was no significant difference in the METs discrepancy between those 
who did or did not report this amount of regular exercise.  Age and peak VO2 are inversely 
related and therefore in older subjects less aggressive protocols are recommended.
137
  Similarly 
the presence of disease may necessitate a more conservative protocol but, again, in this study the 
significant difference in estimated and measured METs was not different regardless of MPS 
result.  Finally, tests longer than 9 minutes in duration were significantly more likely to produce 
a greater peak METs discrepancy.  A contributing factor to this time-dependent difference may 
be the equation used to estimate METs.  This equation, used in the current study and in most 
stress testing labs, is based on a treadmill speed and grade that will result in walking throughout 
the entire test.   However during the 4
th
 (≥9 minutes) or 5th (≥12 minutes) stage of the Bruce 
Protocol, a number of patients will begin to jog or run to keep up with the pace (4.2 mph/16% 
grade and 5.0 mph/18% grade, respectively) of the belt.  An established equation that accounts 
for this alteration in gait pattern exists and its use may likely be warranted.
134
  Future iterations 
of software would benefit from flexibility in the use of the most appropriate equation based on 
the running or walking status of the patient during the test.  Even so, while the results of the 
current study indicate use of the jogging/running equation for those completing > 9 minutes of 
the Bruce Protocol significantly reduces the peak METs discrepancy, a substantial 
overestimation appears to persist.  Therefore, development of alternate regression equations to 
better estimate the oxygen requirement of jogging or running may be necessary. 
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 Another significant contributor to the difference in measured and estimated METs is the 
use of the front handrail by all subjects in this study.  Handrail use decreases sub-maximal VO2 
and HR and impacts estimates of exercise capacity for any given treadmill time.
138, 139
  
Moreover, treadmill time is increased when handrail use is allowed.  The impact of handrail 
support was recognized as contributing to the variability in exercise duration during the 
development of the Bruce Protocol itself and therefore, was not allowed, although it is not clear 
if the creators of the DTS followed this same convention.  In the present investigation the degree 
of handrail assist was not assessed and can therefore be viewed as a limitation of this study.  The 
lack of control for handrail use was, however, prospectively and intentionally conceived in order 
to capture a more accurate reflection of current clinical practice patterns in an exercise stress 
testing laboratory.  While published guidelines advocate for the elimination/minimization of 
handrail use during exercise testing on a treadmill,
137
 it is likely that the use of handrails is 
commonplace
140
 in clinical practice and will persist due to perceived safety concerns.  A way to 
objectively measure and account for the impact of handrail use on estimated VO2 would 
therefore be an important contribution, allowing for clinicians to more accurately quantify a 
subject’s aerobic capacity.   
 The current study reveals that the DTS calculated with treadmill time fails to indentify a 
positive MPS result in women while the converse was true in men.  Even so, while statistically 
significant, the diagnostic model for DTS calculated with treadmill time in males was relatively 
weak.  Additionally, when measured VO2 was used to calculate DTS a statistically significant, 
albeit weak, model for both men and women is elucidated.  The explanation for this may lie in 
the differences between the cohort of patients included in the current investigation and the one in 
which the tool was developed.  First, the original cohort was mostly men.
125
  In the later 
77 
 
diagnostic validation of the DTS the vast majority of subjects who had a high risk score were 
also men (91%) and the DTS was shown to be most effective at identifying significant or severe 
disease.
141
  In the current study, there was a very low incidence of severe perfusion defects and 
roughly half of the patients were female.  Therefore, it may be the DTS is a more robust 
diagnostic tool in cohorts more closely approximated to the characteristics of the subjects in 
which it was originally developed.  From a prognostic standpoint, the DTS is frequently used to 
define risk for future adverse events in subjects undergoing an exercise stress test.  The results 
presented here indicate the overestimation of aerobic capacity from peak estimated METs may 
falsely lower risk estimates for a large number of individuals undergoing this examination, which 
may have important implications for medical management.   
 An error in the estimation of aerobic capacity itself has several important implications 
without consideration of other variables obtained from exercise testing.  First, overestimation of 
exercise capacity results in an underestimation of risk. In this study true aerobic exercise 
capacity was overestimated by at least 1 MET in approximately three-quarters of the subjects 
assessed.  Moreover, true aerobic capacity was overestimated by at least 2 METs in more than 
half of the subjects assessed. This may have significant implications for the underestimation of 
future risk for morbidity and mortality according to aerobic capacity.
129
  Admittedly, the recent 
meta-analysis by Kodama et al.
129
 clearly demonstrated an estimated calculation of peak METs is 
highly prognostic despite its potential to overestimate true aerobic capacity.  However, it is 
unknown if a more accurate quantification of aerobic capacity would further improve the already 
robust prognostic value of aerobic capacity estimated from treadmill speed, grade and/or time.  
This is an important issue for future investigations given the clear clinical value in assessing 
aerobic exercise capacity in numerous populations.
137
  Like the DTS, an underestimation of risk 
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through an overestimation of aerobic capacity alone may also impact therapeutic decisions.  In 
those with an exercise capacity of 10 METs or more, prognosis is considered the same for 
medical therapy or coronary artery bypass surgery.
3
  In the present study, 117 subjects achieved 
at least 10 METs when they were estimated whereas only 15 subjects achieved the same 
important threshold when peak METs were measured (p<0.001).  Alternately, a less than 5 MET 
exercise capacity is a well-recognized threshold indentifying those patients with a particularly 
poor prognosis
3
 and significantly more patients in this investigation failed to surpass this 
threshold when using measured compared to estimated values (72 vs. 20, p <0.001).   Finally, 
regular aerobic exercise training is a well-recognized lifestyle intervention with a positive impact 
on morbidity and mortality.
142
  Exercise stress testing affords clinicians the opportunity to 
discuss the initiation/maintenance of an aerobic exercise regimen.  The appropriate moderate 
exercise intensity range (typically 3-6 METs) should be based upon the patient’s test result.  An 
exercise program developed from an inflated estimate of aerobic capacity could conceivably 
result in the recommendation to engage in activities that would be at a much greater intensity 
than intended.   
 A limitation of this study is the lack of cardiac catheterization data to confirm the MPS 
results.  This is due to the relatively mild perfusion defects detected and the lower risk profile of 
many of the included subjects resulting in the clinical decision to defer further invasive testing.  
However, previous research has demonstrated a positive MPS is a significant predictor of 
adverse events regardless of catheterization findings.
143
  Moreover, several studies have shown 
the prognostic significance of endothelial dysfunction in patients, especially women, with 
“normal” coronary arteries.144  The limitations of coronary angiography have been described 
extensively.
38
  For example, in patients with chest pain but negative catheterization, intravascular 
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ultrasound, which assesses anatomy beyond lumen diameter, consistently show morphological 
changes throughout the arterial tree.
145, 146
   
 In conclusion, this study demonstrates the estimation of peak VO2 can lead to clinically 
meaningful errors in the assessment of patients with suspected CAD referred for exercise stress 
testing.  Specifically, estimation of aerobic capacity portrays an exaggerated level of fitness and 
diminished risk for future adverse events.  The accurate quantification of exercise capacity is of 
utmost importance given its strong association with outcome in multiple disease conditions.  
Cardiopulmonary exercise testing is the only way to directly measure exercise capacity, but 
currently CPX is not a standard part of a functional capacity assessment.  This may be in part due 
to the size and expense of the equipment needed; however, modern metabolic carts are smaller to 
the point of being nearly portable and have become more affordable.  Moreover, many more 
professionals are becoming expert in the performance of this test, removing the barrier of a lack 
of trained personnel.  Despite this, the estimation of exercise capacity from the standard exercise 
stress test will undoubtedly continue and therefore efforts should be made to: 1) improve the 
administration of these tests with the goal of better individualization (i.e. selection of an 
appropriate exercise protocol) and closer adherence to established guidelines (i.e. minimization 
of handrail use when possible),
147
 2) improve the ability to quantify estimated aerobic capacity 
through exercise time and/or workload by developing regression equations with greater 
precision, and 3) ensure future iterations of exercise testing software integrate the most accurate 
means of estimating aerobic capacity with automated flexibility in the regression equations used 
(i.e. transition from walking to jogging/running).     
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Table 1:  Exercise and Ventilatory Data 
 Whole Cohort  Males Females 
Max HR (bpm) 150  ±19.0 147.8 ±19.2* 152.3 ±18.6 
PPMHR (%) 88.2 ±10.2 87.4 ±10.7 89.1 ±9.6 
Max SBP (mmHg) 185.5 ±25.1 191.1 ±24.8* 179.6 ±24.2 
Max DBP (mmHg) 88.1 ±15.6 87.9 ±16.5 88.2 ±14.6 
TM Time (sec) 429.1 ±164.6 481.5 ±176.1* 372.8 ±130.2  
Peak VO2estimated (mL•kg
-1•min-1) 30.7 ±9.8# 33.7 ±10.8*,# 27.4 ±7.3# 
Peak VO2measured (mL•kg
-1•min-1) 22.8 ±6.7 25.5 ±7.1* 19.9 ±4.8 
% Predicted VO2(measured/predicted)*100 95.3 ±26.7# 91.7 ±27.0*
,# 
99.2 ±25.9
# 
 % Predicted VO2 (estimated/predicted)*100 129.2 ±42.0 122.5 ±41.2* 136.4 ±41.3 
Peak METsestimated 8.8 ±2.8# 9.6 ±3.1*
,# 
7.8 ±2.0
# 
Peak METsmeasured 6.5 ±1.9 7.3 ±2.0* 5.7 ±1.4 
DTSmeasured 2.7 ±3.5# 3.3 ±3.5*
,# 
2.1 ±3.5
# 
DTStime 5.8 ±4.6 6.9 ±4.6* 4.7 ±4.2 
# p <.001 estimated vs. measured calculation of aerobic capacity 
* p <.05 males vs. females 
Abbreviations: HR: heart rate; bpm: beats per minute; PPMHR: percent predicted maximum heart rate; SBP: systolic blood 
pressure; DBP: diastolic blood pressure; mmHg : millimeters mercury; TM: treadmill; sec: seconds; VO2: ventilatory oxygen 
consumption; METs: metabolic equivalents; DTS: Duke Treadmill Score.   
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Table 2: Peak MET Discrepancy Based on Gender Considering Age, Physical Activity, MPS 
Result and Treadmill Time 
  All (n=303) Males (n=157) Females (n=146) 
Age (years) 
< 40 -2.8 ±2.2 (n=51) -3.2 ±2.5 (n=28) -2.2 ±1.7 (n=23) 
40-60 -2.2 ±1.9 (n=183) -2.3 ±2.2 (n=87) -2.2 ±1.6 (n=96) 
>60 -2.0 ±2.0 (n=69) -2.0 ±2.3 (n=42) -2.1 ±1.4 (n=27) 
Physical Activity 
Status (days/week) 
0-3 -2.1 ±1.9 (n=175) -2.1 ±2.2 (n=79) -2.1 ±1.6 (n=96) 
4-7 -2.5 ±2.1 (n=128) -2.6 ±2.3(n=78) -2.3 ±1.6 (n=50) 
MPS Result 
Neg./Equiv. -2.3 ±2.0 (n=271) -2.5 ±2.4 (n=135) -2.2 ±1.6 (n=136) 
Mild-Severe -1.6 ±1.5 (n=32) -1.3 ±1.4 (n=22) -2.3 ±1.7 (n=10) 
TM Time 
(minutes) 
≤9 -1.7 ±1.5 (n=237)* -1.6 ±1.6* (n=105) -1.9 ±1.4 (n=132)* 
>9 -4.2 ±1.6 (n=66) -4.2 ±1.7 (n=52) -4.1 ±1.2 (n=14) 
* p < 0.001 METs discrepancy  ≤9 vs. >9  
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Figure 1: Comparison of Estimated and Measured VO2 
*p <0 .01 estimated vs. measured 
#p < 0.01 men vs. women 
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Figure 2: Peak METs Discrepancy Using the Walking vs. the Jogging/Running Equation  
*p < 0.01 walking vs. jogging/running 
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